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Abstract 
 Using natural supplementation as a treatment tool for mental health problems is 
becoming increasingly popular. Several studies using a multinutrient supplement called 
EMPowerplus (EMP+) have been conducted in humans with disorders such as Attention-
Deficit/Hyperactivity Disorder (ADHD), but no studies have been conducted in animals or 
humans without disorders. Therefore, to address the gaps in the literature, the aim of this 
study was to assess the effects of EMP+ in a rat population on anxiety, aggression, and 
impulsivity which may be present in people who do not have a disorder. To investigate this, 
40 male and 40 female rats were fed a diet consisting of 0%, 1.25%, 2.5% or 5% EMP+. 
They were tested during adolescence (PND 52-53) and again during mid-adulthood (PND 
116-117) for anxiety and aggression, and during early adulthood (PND 92-96) and again 
during late adulthood (PND 127-130) for impulsivity. Due to the impact of the September 4
th
 
2010 7.1 magnitude earthquake, data for some rats had to be excluded from anxiety and 
aggression analyses, leaving a sample size of 29 males and 34 females. Although there were 
no treatment main effects for any of the three behaviours, there were significant interaction 
effects between treatment and sex for measures of anxiety and aggression, showing that each 
sex reacted differently to the supplement. Male rats became less anxious, while female rats 
became more anxious. Of the five aggressive behaviours observed, significant interactions 
were found between treatment and sex for rough paw and allogrooming frequency. There 
were no significant effects involving treatment for impulsivity, but male rats were more 
impulsive when they were older (PND 127-130). Overall, the effects of EMP+ on the rats’ 
anxious, aggressive, and impulsive behaviours were mixed, and it is likely that the 7.1 
magnitude earthquake and its subsequent aftershocks played a role in these results.  
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1.0 Introduction 
1.1 General Overview 
The use of multinutrient supplementation as a treatment tool for disorders such as 
ADHD, Obsessive-Compulsive Disorder (OCD), and bipolar disorder is becoming 
increasingly popular. One particular 36-ingredient micronutrient formula known as EMP+ is 
showing great potential for treating the symptoms of these disorders. While the findings of 
studies using EMP+ are promising, these particular studies focus solely on people with 
serious disorders. It is just as important to look at the effects of this supplement in people 
who do not have a serious disorder. Those without disorders such as ADHD can still present 
with general mental health issues of lesser severity such as anxiety, aggression, and 
impulsivity, so this population may also benefit from the effects of the supplement. 
Additionally, it is necessary to establish what effect EMP+ would have on a person without a 
disorder because they are quite different to a person with a disorder. A supplement that is 
beneficial for one population, like those with a serious disorder, may not be beneficial for 
another, so it is necessary to establish whether any harmful effects may result if someone 
without a disorder were to take the supplement. It is also possible that no effects may result 
from taking the supplement in a person without a disorder, so it would be wasteful for them 
to use the supplement. Furthermore, the supplier of EMP+ makes a dose suggestion for 
targeting “general health” issues, but it is unclear what the benefits would be for a person 
without a serious disorder. 
As well as the literature being limited to people with a serious disorder, there is no 
published research concerning effects of EMP+ in a rat population. Rat studies are important 
for establishing an initial framework of understanding and are useful due to the amount of 
control that can be exerted over the subjects and conditions of the experiments. Specifically, 
rats are not likely to cause the problems that humans do such as abusing drugs, missing 
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appointments, and not taking the supplement. Therefore, to help address the gaps in the 
literature outlined above, the primary aim of this study was to investigate the effects of 
EMP+ on anxiety, aggression, and impulsivity in a population of rats that were not animal 
models of any serious human disorders (from now on referred to as a normal rat population). 
These three behaviours were chosen because they are commonly experienced in people who 
do not have a serious disorder. It is hoped that the beneficial effects of EMP+ are not limited 
to people who have a serious disorder and that this method of treatment can be beneficial for 
more general health issues. While the current study involved rats, it was felt that the results 
might have some implications for humans and might thus warrant further research with a 
human population. 
 
1.2 EMP+ 
Initial studies in the late 1970s to early 1980s looked at the effects of megavitamins in 
children. While some found reductions in problem behaviours such as hyperactivity, most 
were inconclusive and showed that mega-doses of vitamins might be toxic (Arnold et al., 
1978; Haslam et al., 1984; Kershner and Hawke, 1979). Since then, a better knowledge and 
understanding of the processes involved with natural supplementation has resulted in a 
promising multi-ingredient formula called EMP+. This supplement contains 14 vitamins, 16 
minerals, three amino acids, and three antioxidants (serving sizes of the main ingredients can 
be found in Table 1).  
 
 
 
 
 
 
4 
 
 
 
Table 1. 
Composition of EMP+ showing amount of each ingredient per serving (4 capsules), for a general health dose 
(8 capsules), for a therapeutic dose (15 capsules), for double the highest recommended dose (30 capsules), 
and the upper intake levels (UL) for each ingredient. 
 
Amount Per General Therapeutic Double UL** 
 
Serving* Health Dose Dose Highest Dose 
 
 
(4 capsules) (8 capsules) (15 capsules) (30 capsules) 
 
  
1.25% EMP+ 2.5% EMP+ 5% EMP+ 
 Vitamin A 1,536 IU 3,072 IU 5,760 IU 11,520 IU
†
 10,000 IU 
Vitamin C 160 mg 320 mg 600 mg 1,200 mg 2,000 mg 
Vitamin D 384 IU 768 IU 1,440 IU 2,880 IU
†
 2,000 IU 
Vitamin E 96 IU 192 IU 360 IU 720 IU 1,500 IU 
Vitamin B1 4.8 mg 9.6 mg 18 mg 36 mg none set 
Vitamin B2 3.6 mg 7.2 mg 13.5 mg 27 mg none set 
Vitamin B3 24 mg 48 mg
†
 90 mg
†
 180 mg
†
 35 mg 
 Vitamin B5 5.8 mg 11.6 mg 21.8 mg 43.6 mg none set 
Vitamin B6 9.6 mg 19.2 mg 36 mg 72 mg 100 mg 
Vitamin B9 384 mcg 768 mcg 1,440 mcg
†
 2,880 mcg
†
 1,000 mcg 
Vitamin B12 240 mcg 480 mcg 900 mcg 1,800 mcg none set 
Vitamin H 288 mcg 576 mcg 1,080 mcg 2,160 mcg none set 
Calcium 352 mg 704 mg 1,320 mg 2,640 mg
†
 2,500 mg 
Phosphorous 224 mg 448 mg 840 mg 1680 mg 4,000 mg 
Magnesium 160 mg 320 mg 600 mg
†
 1,200 mg
†
 350 mg 
Potassium 64 mg 128 mg 240 mg 480 mg none set 
Iodine 54.4 mcg 108.8 mcg 204 mcg 408 mcg 1,100 mcg 
Zinc 12.8 mg 25.6 mg 48 mg
†
 96 mg
†
 40 mg 
Selenium 54.4 mcg 108.8 mcg 204 mcg 408 mcg
†
 400 mcg 
Copper 1.9 mg 3.8 mg 7.1 mg 14.2 mg
†
 10 mg 
Manganese 2.6 mg 5.2 mg 9.8 mg 19.6 mg
†
 11 mg 
Chromium 166.4 mcg 332.8 mcg 624 mcg 1,248 mcg none set 
Molybdenum 38.4 mcg 76.8 mcg 144 mcg 288 mcg 2,000 mcg 
Iron 3.7 mg 7.4 mg 13.9 mg 27.8 mg 45 mg 
Proprietary Blend 444.1 mg 882.2 mg 1,654.1 mg 3,308.2 mg none set 
Proprietary blend consists of dl-phenylalanine, glutamine, citrus bioflavanoids, grape seed extract, chlorine 
bitartrate, inositol, ginkgo biloba, methionine, germanium sesquioxide, boron, vanadium, nickel.  
* Supplement composition information is available from the developer’s website (http://www.Truehope.com)  
** ULs found in Simpson et al., 2011. 
† 
UL is exceeded for this dose. 
 
For general mental health issues such as anxiety, two servings of four capsules each 
per day are recommended, which is equivalent to a diet that contains 1.25% EMP+. This 
dosage applies to people without a more serious disorder who have general problems such as 
anxiety, aggression, and impulsivity. This was the target population of this study so was 
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included as a treatment condition. This dosage is increased to approximately 15 capsules per 
day for a therapeutic dose aimed at targeting mental health disorders such as ADHD and 
bipolar disorder. This is equivalent to a diet consisting of 2.5% EMP+ and was also included 
in this study to see if it is safe for a normal healthy population to take a dose aimed at those 
with a mental disorder. Additionally, a dose of 5% EMP+ was included to evaluate the effects 
of taking double the highest recommended dose, and a control group was also included to 
allow comparison between all three treatment groups and rats not on the supplement. 
For four of the ingredients, vitamin B3, vitamin B9, magnesium, and zinc, the full 
daily dose exceeds the upper intake level (UL) when a therapeutic dose is taken. However, 
there have been no problems reported so far resulting from taking this supplement, and there 
are accordingly no safety concerns (Simpson et al., 2011). Skin flushing is only a concern 
when vitamin B3 is taken in excess, and the UL was set at 35mg to try and prevent this. 
Taking vitamin B9 in excess of 1000mcg could mask a vitamin B12 deficiency, but this is of 
no concern because of the B12 content in the supplement. Diarrhoea is of concern if the UL 
of magnesium is exceeded, but there have been no reports of this so far. Finally, the zinc UL 
was set to avoid an imbalance of copper, but this is unlikely because of the copper content of 
the supplement (Simpson et al., 2011). More importantly, only one of the UL’s is exceeded 
when a dose for general health purposes is taken, which is vitamin B3, and not by much. 
Therefore, if the results of the current study on rats prove promising, there should be minimal 
concerns over using EMP+ to treat general health problems such as anxiety, aggression, and 
impulsivity in people without a disorder. 
It is not surprising that several more UL’s are exceeded when double the 
recommended therapeutic dose is taken. Table 2 describes some of the symptoms associated 
with toxicity of these, including symptoms associated with the four ingredients already 
covered when a therapeutic dose is taken. 
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Table 2. 
Toxicity symptoms of EMP+ ingredients that are exceeded when a general health dose is taken (8 capsules), 
when a therapeutic dose is taken (15 capsules), and when double the highest recommended dose is taken (30 
capsules). 
Nutrient Associated Toxicity Symptoms 
Vitamin A* Headache, diplopia, dermatitis, anemia, insomnia, bone abnormalities, 
 
     liver damage, hypercalcemia, and menstrual irregularities. 
Vitamin D* Nausea, vomiting, excessive thirst and urination, muscular weakness, 
 
     joint pain, and calcification of the heart, lungs, and kidneys. 
Vitamin B3#†* Nausea, heartburn, fatigue, dry hair, sore throat, inability to focus 
 
     eyes, vascular dilation, and gastrointestinal irritation. 
Vitamin B9†* Can obscure the diagnosis of pernicious anemia, may reduce zinc 
 
     absorption, and precipitates in kidneys of laboratory rats. 
Calcium* Nausea, constipation, hypertension, hypercalcemia, kidney stones, 
 
     myopathy, and may inhibit absorption of iron and zinc. 
Magnesium†* Nausea, diarrhoea, hypotension, bradycardia, vasodilation, EKG 
 
     changes, coma, and cardiac arrest. 
Zinc†* Gastrointestinal irritation, vomiting, impairment of copper status, 
 
     microcytic anemia, and impairment of immune responses. 
Selenium* Fingernail changes, hair loss, nausea, abdominal pain, diarrhoea, 
 
     fatigue, irritability, and peripheral neuropathy. 
Copper* Nausea, gastric pain, diarrhoea, vascular collapse, and interacts with 
 
     zinc, cadmium, and molybdenum in the body. 
Manganese* Can cause severe psychiatric disorder, reproductive and immune 
 
     system dysfunction, and kidney and liver disorders. 
Note: Adapted from Driskell, 1992. 
# exceeded when a general health dose is taken 
† exceeded when a therapeutic dose is taken 
* exceeded when double the highest recommended dose is taken 
 
 Table 2 illustrates the undesirability of taking too much of any of these nutrients, 
which has implications for EMP+. Health warnings should highlight these possible risks to 
ensure that no-one takes too much of the supplement. 
 
1.3 Anxiety, Aggression, and Impulsivity 
 Anxiety is one of the most prevalent health mental disorders, with children and 
adolescents having rates as high as 7-25% (Jimerson, 2003). It is likely that the rate of 
anxiety symptoms in a population of children and adolescents that are not diagnosed with an 
anxiety disorder is much higher. In well functioning older adults, anxiety symptoms occurred 
in 15% of those without depression, with women more likely to have symptoms than men 
(Mehta et al., 2003). Anxiety in children is characterised by excessive worry and concern, 
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exaggerated fear, stranger and separation anxiety, and inhibition, which are often associated 
with physical complaints such as headaches and nausea (Minnesota Association for 
Children’s Mental Health, 2011). Anxiety symptoms in adults are similar to those of children, 
with the excessive worry and concern focused more on their daily activities as opposed to 
fear of separation. Normal healthy individuals will experience these symptoms of anxiety 
from time to time, but those who worry so excessively that it interferes with their lifestyle 
may qualify for a diagnosis (Ciechanowski and Katon, 2011). In rats, the anxiety response is 
characterised by freezing, particularly when they are in an open space, with faecal boli more 
common when a rat is more anxious (Ennaceur et al., 2006). A more anxious rat will also 
startle more, as evidenced by higher startle amplitudes in response to a sudden noise (Koch, 
1998). 
 Aggression is a common and disruptive behavioural problem that can be described in 
a number of ways depending on the target, type, and cause of aggression, and is commonly 
classified as being either premeditated or impulsive (Siever, 2008). In psychiatric inpatients, 
aggression was recorded in 13.7% of patients, with the most common forms of aggression 
being verbal threats, loud and demanding manner, and battery of a person with physical force 
(Barlow et al., 2000). In children, aggressive behaviour is a common reason for clinical 
referral, with aggression being more maladaptive in children with a psychiatric disorder than 
those who are not referred (Bambauer, 2005). Aggressive behaviours in rats are usually 
referred to as defensive responses, and include behaviours such as bite attacks, rough 
grooming, chasing, and mutual upright boxing (Johns and Noonan, 1995; Miczek and de 
Boer, 2004). 
 Impulsivity is a behaviour commonly associated with ADHD, and is characterised by 
a tendency to act without thinking or engage in risk taking behaviours without considering 
consequences (Virtual Medical Centre, 2011). The worldwide prevalence of ADHD is 
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estimated to be 5.29% (Polanczyk et al., 2007), with the adult prevalence rate estimated to be 
4.4% (Kessler et al., 2006). Impulsive behaviour is not limited to ADHD, and is instead 
referred to as trait impulsivity which can be measured using the Barratt Impulsiveness Scale 
(Hollander et al., 2005; Steinberg et al., 2008). In rats, impulsivity is commonly assessed by 
measuring their tolerance to the delay of a reward, or in other words their decisions regarding 
the costs and benefits of delay and effort to gain a reward (Thiébot et al., 1985; Evenden and 
Ryan, 1996; Denk et al., 2005). Impulsivity is displayed when the rat chooses to gain a small 
immediate reward instead of a larger delayed reward. 
 
1.4 Rat Studies 
 To date there has been no research into the effects of EMP+ on any types of behaviour 
in rats. Therefore, it is difficult to make predictions about how the current rat population 
might behave when on the supplement. However, it is possible to look at how particular 
ingredients in EMP+ could affect the rats’ anxiety, aggression, and impulsivity levels, as 
outlined by previous research. This is done in the following three sections. 
 
 1.4.1 Anxiety 
 Studies have looked at the effects of vitamins A, C, D, and E on anxiety in rats. Rats 
tested in an open field and elevated plus maze, both of which are commonly used to examine 
anxiety levels in rats, showed no alterations in anxiety levels after chronic administration of 
13-cis-retinoic acid (a derivative of vitamin A) (Dopheide and Morgan, 2008). It has been 
shown that pharmacological doses of vitamin A can induce anxiety-like behaviour in rats (de 
Oliveira et al., 2010). Rats exposed to a chronic dose of vitamin A exhibited increased 
anxiety as evidenced by a higher number of refusals for entering the light compartment in the 
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light-dark task (de Oliveira et al., 2007). However, the doses of vitamin A in these studies 
were large, and the increases in anxiety were likely a result of toxic effects. 
Rats have shown decreased anxiety levels as measured by the open-field task and 
acoustic startle when consuming vitamins C and E either separately or combined together in 
their drinking water (Hughes et al., 2011). Conversely, vitamin E has been shown to increase 
anxiety in Wistar rats while not affecting anxiety levels in OXYS rats (Kolosova et al., 2006). 
A further study has shown that vitamin D deficiency doesn’t affect anxiety in mice (Harms et 
al., 2008). 
The effects of a few minerals on rats’ anxiety have also been assessed. Anxiety was 
unchanged in a study that maintained rats on water containing 1% calcium gluconate for three 
days (Godinho et al., 2002). Increased anxiety was observed in the elevated plus maze task in 
rats after exposure to manganese, as evidenced by a reduction in the percentage of time spent 
in the open arms of the maze (Bouilleret et al., 2011). Lastly, it has been shown that zinc 
deficiency significantly increases anxiety-like behaviours, which was also shown by a 
reduction in time spent in the open arms of the elevated plus maze (Cope et al., 2011). 
It is clear that the vitamins and minerals in EMP+ have different effects on anxiety, 
with some increasing and some decreasing anxiety levels. This highlights an important issue. 
When testing the rats for anxiety using EMP+, it will be difficult to know which ingredients 
are responsible for any behavioural changes. If decreases in anxiety are found we can say that 
EMP+ was beneficial, but only a few of the ingredients may have been responsible for the 
changes. 
 1.4.2 Aggression 
 Other studies have looked at the effects of vitamin A, potassium, manganese, copper 
and zinc on aggression in rats. Chronic administration of 13-cis-retinoic acid reduced 
aggression related behaviours such as bite attacks in adults when tested in the resident-
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intruder paradigm (Trent et al., 2009). Aggression levels of those in the treatment group 
significantly decreased at seven and 14 days after treatment, and these aggression levels were 
significantly lower than the controls. These were reversed to pre-treatment levels following 
one week cessation of drug treatment. Studies suggest that prenatal zinc deficiency can be a 
cause of aggression in the adult rat (Halas et al., 1975; Peters, 1978). It is possible that a diet 
supplemented with zinc could decrease levels of aggression, although there is no direct 
evidence for this. Following long-term ingestion of manganese or copper salt, male rats 
exhibited lowered levels of aggression as evidenced by significant decreases in aggressive 
behaviours such as boxing and fighting (Bataineh et al., 1998). These studies all demonstrate 
the beneficial effects of vitamins and minerals for aggression. 
Interestingly, potassium given to rats on a chronic large dose schedule has been 
shown to facilitate shock-induced aggressive behaviours, increasing them by 11.4% (p<0.05) 
(Eichelman et al., 1973). This may have been due to toxicity as a result of the chronic dose, 
so it would be necessary to review the effects of lower potassium doses on rat behaviour to 
see if they reduce aggression. While this result is not in support of using EMP+ to treat 
aggression, it is necessary to consider the larger number of benefits of its other ingredients in 
treating aggression. As with testing for anxiety, any changes associated with EMP+ can only 
be attributed to the supplement as a whole, and not to any of the individual ingredients. 
 
 1.4.3 Impulsivity 
 There appears to be no published available research on the effects of any of the 
ingredients in EMP+ on impulsivity in rats. Research is limited to the effects of drugs such as 
amphetamines, heroin, cocaine, and methylphenidate (a psychostimulant drug approved for 
the treatment of ADHD). 
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1.5 Human Studies 
 Even though the primary focus of this study is rat behaviour, this section will outline 
the research conducted on humans using EMP+ to show how effective the supplement has 
been so far. The literature describing the effects of EMP+ in humans is limited to populations 
with disorders such as ADHD, so there is no literature on the effects of EMP+ in people 
without a serious disorder. However, these studies still look at symptoms such as anxiety, 
aggression, and impulsivity in conjunction with the symptoms associated with the disorders. 
Therefore, since the focus of this study was on anxiety, aggression, and impulsivity, and not 
on disorders themselves, the following sections will draw from the parts of the literature that 
evaluate these particular symptoms. Even though the anxiety, aggression, and impulsivity 
experienced by those with a disorder may be different from that experienced by those without 
a disorder, effects found on these behaviours in the population with a disorder are indications 
of how the supplement will affect these behaviours in a population who do not have serious 
disorders. 
In the early 2000s, the use of EMP+ for treating mental health problems focussed 
mainly on bipolar disorder and mood. More recently, this has been expanded to look at other 
disorders such as OCD, autism (Mehl-Madrona et al., 2010), and ADHD. An open-label case 
series on nine children with a range of mood and behaviour problems, including ADHD, 
produced significant improvements with all effect sizes being larger than 0.8 (Kaplan et al., 
2004). At study entry, at least six of the children scored in the clinical range for anxiety and 
aggression. After approximately 12 weeks on EMP+, there were statistically significant 
decreases in anxiety (p<0.05) and aggression (p<0.01). Participant compliance was high, and 
side effects were minimal. Most importantly, the three children who were on supplement 
during the trial were able to decrease their intake and still benefit from the effects of the 
supplement, thereby reducing any negative side effects as well as any interaction with the 
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supplement. Similar effects have been found in adults (Rucklidge et al., 2011). Of 14 
participants, all with a diagnosis of ADHD and three with generalised anxiety disorder, a 
therapeutic dose of EMP+ significantly decreased the measure of impulsivity in 10 of them 
(p<0.001), lowering their scores to a normal nonclinical range. An effect size of >0.8 was 
found for the drop in self-reported anger and an improvement in the ability to regulate anger. 
Additionally, anxiety as measured by the Depression and Anxiety Stress Scales decreased 
significantly (p<0.01). Like the study with children, compliance was high (97.2%) and side 
effects were minimal. There were some reports of nausea and headaches, but these did not 
last for longer than the first few weeks. A case study of an 18-year old male with OCD 
showed significant reduction in his clinical levels of anxiety after using EMP+ (Rucklidge, 
2009a). After discontinuation of the supplement, his anxiety worsened, with the 
reintroduction of the supplement improving his symptoms again. Another case study of a 21 
year old female with a range of problems including ADHD showed significant improvements 
in anxiety and impulsivity after eight weeks of being on EMP+ (Rucklidge and Harrison, 
2010). As well as exhibiting on and off control of her symptoms with the introduction and 
removal of the supplement, she showed remission from all mental illness after a year of being 
on the supplement. No side effects were reported as a result of the treatment. 
While the above studies tested the effects of EMP+ on people with mental disorders, 
they still looked at the effects of the supplement on participants’ anxiety, aggression, and 
impulsivity ratings. These studies demonstrate the effectiveness of using EMP+ to treat the 
symptoms of anxiety, aggression, and impulsivity, showing that it is a promising method of 
treatment for a population without a disorder who are experiencing symptoms of anxiety, 
aggression, and impulsivity. It was expected that the rat population in the present study might 
be similarly affected. 
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1.5.1 Related Literature 
Several studies illustrating the benefits of supplementation on the aggressive 
behaviours of delinquent juveniles and criminals demonstrate the advantages of micronutrient 
formulas for ameliorating problem behaviour. A well designed double-blind, placebo-
controlled, randomised experiment of 231 young adult prisoners found that those who were 
administered nutritional supplements committed an offence on average 26.3% times less 
(p<0.03) than controls (Gesch et al., 2002). This was equivalent to a 35.1% decrease 
(p<0.001) in offences from baseline in those who received supplementation. Consumption of 
a vitamin-mineral supplement by 32 adolescent delinquents resulted in 28% fewer rule 
infractions of a violent nature than for a placebo group (Schoenthaler et al., 1997). The 
effects of vitamin-mineral supplementation on delinquency have also been investigated in 
children. Schoenthaler and Bier (2000) found a 47% reduction in the need for discipline in 
the 40 children aged six to 12 years who took a daily vitamin-mineral supplement for four 
months compared to the 40 children who took placebos. Behaviours that decreased the most 
were vandalism, refusal to do work, uttering obscenities, and disorderly conduct.  In all cases, 
the supplements used contained a wide range of vitamins and minerals similar to those in 
EMP+. The results of these studies outline the effectiveness of combinations of vitamins and 
minerals for reducing aggression-related behaviours. 
Of particular interest are studies involving over the counter supplements. Berocca is a 
dissolvable tablet containing B vitamins and vitamin C, and has been shown to reduce 
anxiety. A double-blind randomised-control trial of 80 healthy male volunteers found 
statistically significant reductions in anxiety levels of those taking Berocca once daily for 28 
days compared to controls (Carroll et al., 2000). A similar study which included a sample of 
204 women and 96 men found significant reductions in stress, which is closely related to 
anxiety, after taking Berocca for 30 days (Schelbush et al., 2000). The males and females 
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were equally distributed across the control group and treatment group, suggesting that both 
males and females benefited from taking Berocca. Conversely, a review of herbal and dietary 
supplements claims that there is no clinical trial evidence on the effectiveness of Berocca for 
anxiety disorders (Saeed et al., 2007). Additionally, administration of a high dose vitamin B-
complex formula found no significant reductions in anxiety in a three month, double-blind, 
randomised, placebo-controlled trial of 60 participants (Stough et al., 2011). It is likely that 
the effect of a single vitamin is not enough to reduce anxiety by itself, and that a combination 
of vitamins and minerals is necessary for targeting underlying deficiencies in order to reduce 
anxiety. 
 
1.6 Mechanisms of Action 
 The term mechanism of action refers to the specific action through which a substance 
produces its effect on an organism. It is beyond the scope of this article to discuss the 
mechanisms of action of all ingredients in EMP+ in depth. Instead, a brief summary of some 
of the vitamins and minerals in EMP+ that have been more extensively researched will be 
covered to illustrate how they might help reduce anxiety, aggression, and impulsivity. 
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Table 3. 
Brain functions of selected micronutrients in EMP+. 
 
Important functions of selected EMP+ ingredients 
Vitamins A, C, and E Inhibit the destructive effects of oxidation
a
 
Vitamin B1 Involved in the presynaptic release of acetylcholine
b
 
Vitamin B6 Neurotransmitter synthesis and normal brain development
c
 
Vitamins B9 and B12 Involved in processes important for central nervous system function
d
 
Magnesium Neurotransmitter synthesis,
c
  post-synaptic receptor function,
e
 
 
     active transport of ions across cell membranes and for cell signalling
f
 
Zinc Normal growth, immune function, neurological development,
c
  
 
     synaptic transmission and DNA synthesis
e
 
Selenium Protects cells from the effects of free radicals
f
 
Chromium Affects norepinephrine release and tryptophan avaliability
g
 
Iron Normal brain growth, neurotransmitter synthesis and catabolism 
 
     and many cellular metabolic processes
c
 
a 
Brigelius-Flohé and Traber, 1999 
b 
Meador et al., 1993 
c 
Rucklidge et al., 2009 
d 
Bjelland et al., 2003 
e 
Kaplan and Shannon, 2007 
f 
Kaplan et al., 2007 
g
 McLeod and Golden, 2000 
 
 It is clear from Table 3 that the vitamins and minerals present in EMP+ are necessary 
for some very important brain processes, and are therefore vital for normal and healthy 
development. Deficits in these essential micronutrients would result in sub-optimal 
functioning, therefore increasing the likelihood of a disorder. In fact, the approach of using 
natural supplementation for the treatment of disorders such as ADHD is often based on the 
assumption that the disorder is the result of an underlying nutritional deficiency (Rucklidge, 
2009). 
Particular attention has been paid to the B vitamins and their role in altering 
behaviours associated with ADHD, which therefore has implications for impulsivity. It is 
proposed that the molecular structures of the B vitamins, particularly vitamin B1, are similar 
to those of dopamine (Shaw et al., 2011). They may occupy the dopamine transporter (DAT) 
binding site, resulting in an increase in synaptic dopamine level, consequently activating the 
postsynaptic D2 receptor. This receptor has been implicated in the amelioration of symptoms 
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associated with ADHD, such as impulsivity. Methylphenidate (Ritalin) is commonly 
prescribed for ADHD and works by this same mechanism, therefore possibly sharing a 
common neurochemical mechanism of action with the B vitamins. 
Apart from the B vitamins, proposed mechanisms of action for the ingredients in 
EMP+ and their specific link to effects on anxiety, aggression, or impulsivity are hard to 
come by. We know what the effects of the vitamins and minerals are on the brain, and we 
know how some of them can affect behaviour, but we cannot assume a causal link. For 
example, it is known that magnesium deficiency is associated with anxiety (Watts, 1988). It 
is also known that magnesium is important for processes such as neurotransmitter synthesis 
and cell signalling (see Table 3). However, it does not necessarily follow that impairment of 
neurotransmitter synthesis and cell signalling processes cause anxiety. This idea is 
represented generally in Figure 1. To further complicate the issue is the fact that EMP+ is a 
multi-ingredient formula so the mechanism of action of the supplement as a whole may not 
equal the sum of the mechanisms of action of each of its individual ingredients. 
 
 
Figure 1. Diagram summarising the current state of knowledge of the mechanisms of action of EMP+. 
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Kaplan and colleagues (2007) have proposed four explanatory models in an attempt to 
understand the mechanisms by which the micronutrients of EMP+ influence mood and these 
may be helpful for explaining the same processes related to anxiety, aggression, and 
impulsivity. In brief, these hypotheses are that mental problems are a result of inborn errors 
of metabolism, manifestations of deficient methylation processes, the result of the alteration 
of gene expression by nutrient deficiency, or that disorders are long-latency deficiency 
diseases. While these are not specific mechanisms of action like that proposed by Shaw and 
colleagues (2011) for the B vitamins, they allow for an understanding of how EMP+ may 
benefit anxiety, aggression, and impulsivity symptoms when knowledge on the specific 
mechanisms of action is lacking. 
 
1.7 The Present Study 
The present study investigated the effects of EMP+ on levels of anxiety, aggression, 
and impulsivity in a normal rat population. Male and female rats were fed a diet containing 
0%, 1.25%, 2.5%, or 5% EMP+ which was first administered on post natal day (PND) 30 
(childhood) and they had continuous access to this diet during testing. They were tested for 
anxiety and aggression during adolescence (PND 52-53) and again during mid adulthood 
(PND 116-117), and were tested for impulsivity during early adulthood (PND 92-96) and 
again during late adulthood (PND 127-130) to see if being on the supplement further affected 
behaviour over time, and to assess the effects of the supplement at different developmental 
ages. A summary of these ages and their relevant developmental stages can be found in Table 
4 for easy future reference. Male and female rats were used to investigate possible sex 
differences. While findings from animal studies should be applied to humans with caution, 
the results can provide a valid reason for conducting research with a population of humans 
who do not have a disorder. 
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Table 4. 
Summary of developmental stage of rats during each test for both testing phases, and the corresponding age 
in days. 
 
Testing Phase One 
 
Testing Phase Two 
 
 
Developmental Stage PND Developmental Stage PND 
Anxiety and Aggression Adolescence 52-53 Mid Adulthood 116-117 
Impulsivity Early Adulthood 92-96 Late Adulthood 127-130 
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2.0 Aims and Hypotheses 
To date the literature on the effects of EMP+ on behaviours such as anxiety, 
aggression, and impulsivity in a normal rat population is severely lacking. It is important that 
such research is carried out as testing of this supplement on humans is, while relatively new, 
well underway. The current research aimed to investigate the effects of EMP+ on anxiety, 
aggression, and impulsivity in a normal rat population, and to throw some light on where 
future investigations should be directed. 
Firstly, it was expected that compared to controls, rats on the supplement would 
exhibit lower anxiety, aggression, and impulsivity levels. Presumably, this effect would be 
dose dependent i.e. those on a higher dose of EMP+ would exhibit lower levels of the 
behaviours than rats on a lower dose, with the exception of those on the 5% diet that might 
exhibit increased levels of anxiety, aggression, and impulsivity due to toxic levels of the 
supplement. Secondly, it was expected that any effects of the supplement would become 
more pronounced over time. Specifically, if the supplement resulted in reduced anxiety, 
aggression, and impulsivity levels at one phase of testing, it should continue to do so over 
time, producing even lower levels of anxiety, aggression, and impulsivity at a second phase 
of testing. Little is known about any differences in effects of EMP+ on each sex in a rat 
population. Therefore, while it was expected that some sex differences would be apparent, the 
direction and extent of these for each of the behaviours measured could not be predicted. 
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3.0 Method 
3.1 Subjects 
Eighty male and 80 female hooded rats of the PVG/C strain bred in the Animal 
Facility, Department of Psychology at the University of Canterbury, were used as subjects for 
the present study. On PND 30, the rats were weaned and housed in plastic cages with inner 
dimensions of 440×270×210mm. They were housed in small groups of two to four rats of the 
same sex for the duration of the experiments, unless specified otherwise. They were 
maintained on a 12-hour light/dark cycle (lights on at 0800 hours) and behavioural testing 
was conducted during the light portion of the cycle. All animals were kept in a holding room 
with a regulated temperature of 21
◦
C (± 2
◦
C) and humidity of 45-50%. They had free access 
to food and water in their holding room throughout the duration of experimentation, unless 
specified otherwise. Procedures, approved by the University of Canterbury Animal Ethics 
Committee, minimized the number of animals used in the experiments and their level of 
suffering (see Appendix A). 
Forty of the male and 40 of the female rats were used as intruders for the resident-
intruder paradigm, so were not fed an experimental diet. They always had free access to rat 
pellets and water. Of the rest of the rats, 10 of each sex were randomly allocated on PND 30 
to a diet of 0%, 1.25%, 2.5% or 5% EMP+ resulting in 20 rats in each experimental 
condition. The age when they began the diet corresponds to the childhood stage of 
development in humans (for a relative comparison of human and rat ages and stages of 
development, see Figure 2). For phase one of experimentation, the rats were behaviourally 
tested on measures of anxiety and aggression during adolescence (PND 52-53), and for 
impulsivity during early adulthood (PND 92-96). For phase two of experimentation, the rats 
were tested on measures of anxiety and aggression during mid adulthood (PND 116-117), and 
for impulsivity during late adulthood (PND 127-130). 
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 RATS AGE (days) HUMANS 
  0 
    Infant 
 10 
    Young Child 
 20 
    Childhood 
 30 
     
← diet administration 
40 
    Adolescence 
 50 
     ← startle and resident 
60 
    Young Adult 
      intruder, phase one 
70 
    
  80 
    Early Adulthood 
 90 
    
 
← impulsivity, phase one 
100 
    Mid Adulthood 
 110 
    
 
← startle and resident 
120 
    Late Adulthood 
      intruder, phase two 
130   
 
 ← impulsivity, phase two 
250     Aged 
  
Figure 2. A relative comparison of ages and stages of human versus rat development, showing at which 
stage each procedure occurred (Spear, 2000). 
 
The rats were supplied in four different cohorts every two weeks, and the number of 
rats in each cohort varied depending on how many rats were available. Therefore, the number 
of rats in each cohort was not exactly the same. Consequently, even though best efforts were 
made to produce an equal representation of both sexes and all four diet groups in each cohort, 
this was not possible. Table 5 shows how many rats were received in each cohort and what 
diet group they were allocated to. 
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Table 5. 
Description of each cohort showing how many of each sex were allocated to which diet group. 
 
Sex Diet N 
Cohort 1 F 0% 4 
(N=24) F 1.25% 4 
 
F 2.5% 4 
 
M 1.25% 4 
 
M 2.5% 4 
 
M 5% 4 
Cohort 2 F 0% 4 
(N=20) F 2.5% 4 
 
F 5% 4 
 
M 0% 4 
 
M 1.25% 4 
Cohort 3 F 0% 2 
(N=19) F 1.25% 3 
 
F 2.5% 2 
 
F 5% 3 
 
M 0% 3 
 
M 2.5% 3 
 
M 5% 3 
Cohort 4 F 1.25% 3 
(N=17) F 5% 3 
 
M 0% 3 
 
M 1.25% 2 
 
M 2.5% 3 
 
M 5% 3 
  
Total N  = 80 
Note: There was an equal number of male and female rats received in each cohort. Half were used as intruders 
for the R-I paradigm and are not represented in this table because they were not allocated to an experimental diet 
group. Therefore, the total number of rats received in cohort 1 was 48, in cohort 2 was 40, in cohort 3 was 38, 
and in cohort 4 was 34, giving a total of 160 rats. The above resulted in 10 males and 10 females being in each 
of the four diet concentration groups.  
 
3.2 Diet and Rationale for Doses 
 The EMP+ supplement was donated by the manufacturer, TrueHope (Canada). Rat 
pellets were crushed and the appropriate amount of EMP+ powder was weighed and mixed 
with this to attain the correct diet percentages. Approximately 60ml of distilled water per 
100g of diet was added to produce the desired consistency, and placed in a small bowl. Each 
cage of rats was given 100-300g of food each time they were fed which was approximately 
three times a week. Because rats were housed in groups of two to four per cage, it was 
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difficult to tell exactly how much each rat ate. Additionally, rats often scattered the food 
around their cage, making it even more difficult to measure how much was consumed. 
Therefore, even though the rats were eating food that contained the appropriate percentage of 
EMP+, it was difficult to measure whether the rats were consuming the equivalent to the 
number of pills that a human would take for either a general health dose (eight capsules), a 
therapeutic dose (15 capsules), or double the highest recommended dose (30 capsules). 
Additionally, all rats were weighed frequently and in all instances every rat was putting on an 
appropriate amount of weight, suggesting they were eating a suitable and healthy amount of 
food. Table 6 shows the composition of the rat pellets that were crushed and used for mixing 
with the EMP+. 
 
Table 6. 
Composition of rat pellets showing the ingredients per tonne and the percentage contribution of each 
ingredient. 
Rat Pellet Ingredients Units Per Tonne Contribution (%) 
Barley bulk 100 10 
Soybean meal 48% 300 30 
Wheat bulk 450 45 
Salt, fine 4 0.4 
Methionine 1.25 0.125 
Vitamin E 0.1 0.01 
Lime 12 1.2 
Bentonite 50 5 
Dicalcium phosphate 10 1 
Seltec 0.25 0.025 
Soya oil 40 4 
Molasses 30 3 
PMX RAT 27 1 0.1 
 
 The PMX RAT 27 formula is a mix of vitamins and minerals and its details are 
commercially sensitive and not available for the purposes of this research. The rat pellets 
consisted mainly of wheat, soybean meal, and barley. The contribution of vitamins and 
minerals to the percentage composition of the rat pellets is particularly low, so we can be 
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confident that the rats were getting the concentration of diet that they were allocated, whether 
it be 0%, 1.25%, 2.5%, or 5%, and were not receiving extra nutritional supplementation from 
the rat pellets. Therefore, using the rat pellets as a base mix for the EMP+ powder was not 
likely to enhance any toxic effects of the supplement. 
 A diet consisting of 1.25% EMP+ is the recommended daily dose for general health. 
Since the focus of the study is on reducing general health problems in a normal population, 
this dose was included as an experimental condition. The recommended daily therapeutic 
dose for humans with a disorder such as ADHD is twice this, which equates to a diet 
consisting of 2.5% EMP+. This diet strength was also included to see if it is appropriate to 
give a dose of EMP+ that is aimed at a population that has a disorder, to a population that 
does not have a disorder. Additionally, double the highest recommended dose, i.e. 5% EMP+, 
was included to see if higher levels were potentially detrimental due to toxicity therefore 
worsening the rats’ behaviour. Lastly, a diet of no EMP+ was included to allow for 
comparisons between treatment groups and controls. 
 
3.3 Apparatus and Behavioural Measures 
 In this study, three tests were used to investigate anxiety, aggression, and impulsivity 
in a normal rat population. Anxiety was measured using the startle response, aggressive 
behaviour was measured by the resident-intruder test, and impulsivity was measured using a 
T-Maze. In the startle test, a more anxious animal will produce a higher startle response than 
a calmer or less anxious rat (Koch, 1998). During the resident-intruder test, a more aggressive 
rat will exhibit more aggressive behaviours towards an intruder rat than a less aggressive rat 
(Miczek and de Boer, 2004). Finally, during the T-Maze paradigm, a less impulsive rat 
chooses a larger delayed reward over a smaller immediate reward than a rat that is more 
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impulsive (Thiébot et al., 1985). The experimental room was controlled at 21
◦
C (± 2
◦
C) with 
a humidity of 30% (± 10%).  
On September the 4th, 2010, a 7.1 magnitude earthquake hit Christchurch resulting in 
the closure of the University of Canterbury for nearly two weeks and consequently a 
disruption in the testing of the rats. Since the rats were supplied in cohorts of approximately 
20 experimental and 20 intruder rats at a time, two weeks apart, some rats were tested before 
the earthquake and some were tested after (see Figure 3). For phase one of testing, the first 
three rat cohorts were tested for anxiety and aggression before the earthquake, while the 
fourth and final cohort was tested for anxiety and aggression after the earthquake. Analysis of 
the data showed that startle responses for cohort four were significantly higher than those of 
the other three cohorts. It was presumed that these rats’ responses were affected by the 
earthquake, so they were excluded from all startle analyses (including phase two). Although 
these differences were not significant for the resident intruder data at phase one, it made 
sense to also exclude the resident intruder results of cohort four, as they completed this test 
very soon after the 7.1 earthquake and its subsequent large aftershocks. More detail on this is 
provided in the results section. The impulsivity data for cohort four however was collected a 
substantial time after this and was not affected by the earthquake, so their data remained for 
analyses. All testing for phase two occurred after the initial 7.1 earthquake and was not 
disrupted by any large earthquakes. The above is depicted in Figure 3 which shows clearly 
when the earthquake occurred and how it disrupted testing. While it was deemed too unsafe 
to stay in the laboratory to conduct testing during the period that the University of Canterbury 
was closed, it was still possible to have access to the laboratory to feed the rats. Therefore, all 
rats remained on their supplement diet and no effects of previous supplement consumption 
were lost. 
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Figure 3. Timeline showing when each cohort underwent each experimental procedure, PND at time of 
procedure, and occurrence of the earthquake. PND = post natal day, diet = administration of diet (each 
cohort contained a random mix of males and females, and when possible was comprised of rats from each 
of the 4 diets – control, 1.25%, 2.5%, or 5%), SH = single housing begins, ST = startle procedure, RI = 
resident intruder paradigm, FD = food deprivation begins, TM = T-maze training and testing, * = data 
was excluded due to earthquake interference. 
 
All rats were weaned on PND 30, and experimental rats were introduced to their 
supplement diet on this day. On PND 46 or 47, experimental rats were housed individually in 
preparation for the resident-intruder test (specific experimental procedures are detailed in the 
next sections). On day five or six of being single housed, each rat completed the acoustic 
startle test, followed by the resident-intruder test the next day. However, due to the 
earthquake, this was not the case for the fourth cohort of rats. They were housed on PND 46, 
but the earthquake struck the day after this. Testing was not able to resume for several days 
so they were startled 12 days after being single housed, followed by the resident-intruder 
* 
* 
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paradigm on their thirteenth day of being single housed. On PND 88, the experimental rats 
went on food deprivation for four days in preparation for the T-Maze experiment. The 
process of food deprivation was necessary for making the rats hungry (but not starving) so 
that they would eat the chocolate buds that were used as reinforcement. For each of the four 
days of food deprivation, each cage of rats had access to their food for only 30 minutes each 
day. This was enough time for each rat to eat sufficient food, but meant that they could not 
eat again until the next food deprivation day. They then underwent three days of T-Maze 
training and two days of testing. After each day of training and testing, each cage was again 
given access to their food for 30 minutes. Ad libitum access to their food was regained after 
their final testing day. It was believed that the short period of food deprivation would not 
reduce the levels of EMP+ enough in the rats to significantly affect their performance on the 
impulsivity task. The initial plan was to have all rats start their food deprivation on PND 66. 
This was the case for the first cohort of rats. However, the earthquake prevented the second 
cohort from beginning their food deprivation until PND 88. It was therefore decided that the 
third and fourth rat cohorts would also start their food deprivation on PND 88. 
This whole cycle of testing was completed once more, beginning with single housing 
on PND 109 or 110. However, this time around, the rats were only exposed to two days of T-
Maze training. It was presumed that only two days were needed since they had experience of 
the T-Maze from the first phase of testing. Testing for phase two was not disrupted by any 
large earthquakes, meaning that all rats were the same age when they completed each test, 
give or take a day. 
 
 3.3.1 Acoustic Startle Paradigm 
The rats were placed in one of four identical startle cages (165mm x 80mm x 90mm) 
which were located in sound-attenuating melamine chambers (600mm x 340mm x 560mm). 
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The walls and lid of each startle cage (Med Associates, Fairfield, VT, USA) consisted of 
horizontal stainless steel rods 2.5mm in diameter while the rods comprising each chamber’s 
floor were 4.5mm in diameter. All rods were spaced 15mm apart. A 2.8W lamp and a 60mm 
speaker were housed in a metal frame next to each startle cage. The startle cages were 
mounted on a Med Associates load cell-based startle platform (250mm x115mm x 450mm). 
The acoustic stimulus was produced by a programmable audio generator and consisted of a 
100ms white noise burst with a rise-decay time of 10ms. The ambient noise level in the 
chambers was 36dB as measured by a Bruel and Kjaer sound level meter (A scale, model 
2235; Naerum, Denmark). The Med Associates software (0.5V peak voltage amplitude equals 
100 units) used in the startle paradigm recorded startle amplitudes in response to the white 
noise bursts. This software also controlled the light and white noise. 
On the day of testing, rats were placed in the startle chambers. Testing started after a 3 
minute adaptation period to the chamber. Rats were exposed to 30 noise trials, each with a 30 
second inter-stimulus interval. Each testing session lasted 18 minutes. Rats were removed 
from the chambers and placed back in their single housed cages where they had access to 
their food and water in preparation for the resident-intruder test the following day. 
 
 3.3.2 Resident Intruder Paradigm 
Resident rats were matched with intruder rats for date of birth, sex, and weight. In a 
large number of the cases, the resident rat was larger than the intruder rat. Rats were matched 
by weight like this on purpose to increase the expression of aggressive behaviours of the 
resident rat due to the smaller size of the intruder. Each subject was housed separately in a 
large polypropylene cage (440mm × 270mm × 210mm) for approximately seven days before 
testing. On the day of testing, the single housed resident rats’ cages were placed in the 
observation room, food and water were removed from each cage, and an intruder rat was 
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placed in the cage with the resident rat. The behaviours described in Table 7 were recorded 
for the resident rat over a 15 minute period. Bite attack latency, i.e. time elapsed until the 
resident first bites the intruder, was also recorded. Each intruder was used only once during 
phase one of testing, and only once again during phase two of testing. 
 
Table 7. 
Descriptions of the behaviours observed during the resident intruder paradigm. 
Behaviour Description 
Anogenital Contact Contact of the genital/anal area, usually with nose or paw 
Rough Paw Aggressive pawing of the intruders body 
Allogrooming Aggressive rapid nibbling/grooming of intruder, usually of the neck 
Bite Contact with teeth or tugging at intruders body 
Mutual Upright Position Both resident and intruder face each other in an upright position 
Upright Boxing Pushing and pawing with front legs while both rats upright 
Nose Off Both rats stand immobile facing each other with all paws on ground 
Wrestle Both rats wrap around each other rolling around in a tight ball 
Push/Nudge Resident presses against intruder using broadside of body 
Pinning Resident pins the intruder rat on its back 
Kick Resident kicks intruder with its hind foot 
Pursuit Resident runs after intruder 
Escape Resident runs away from intruder 
Mount Resident places front paws on intruders rump from behind 
Intruder Shriek Intruder lets out a noise as a result of resident’s attack 
 
 3.3.3 Impulsivity in T-Maze 
 Training and trials for the impulsivity experiments were performed in a T-Maze 
constructed from 12mm thick wooden panels with 3mm thick plastic hinged openings on top 
(Figure 4). It consisted of a starting runway (300mm long) and two arms (300mm long) each 
leading to a rectangular goal-box (150mm × 100mm × 140mm). Each arm was equipped with 
two removable 25mm thick wooden guillotine doors that could be inserted into the vertical 
clefts. The right goal-box always contained the large reward (four dark chocolate buds), 
while the left goal-box always contained the small reward (one dark chocolate bud). The 
pellets were placed at the far wall of the goal-box before each trial began. 
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Figure 4. Schema of the T-maze. A = arm, C.A = choice area, C1 and C2 = clefts for guillotine doors, G.B 
= goal-box, S.R = starting runway, p = pellets of chocolate, cm = centimetres. 
 
 For training, the rats were placed one at a time into the starting runway. As soon as 
they entered one of the goal-boxes, a guillotine door was inserted behind them (C2). The rat 
was removed once all chocolate pellets had been eaten and returned to its home cage for an 
intertrial interval of three minutes. Their choice was recorded, as well as the time it took them 
to choose a goal-box, and the total time for each trial (usually less than two minutes once 
trained). Each rat underwent this procedure ten times a day (five in the morning, five in the 
afternoon). Within three days of training, most rats were choosing the larger reward 80% of 
the time for phase one of testing, which suggested they were ready for testing (Thiébot et al., 
1985). Training lasted for two days for phase two of testing. 
 After training, rats underwent two days of trials where increasing delays were 
introduced before receiving the large reward. On the first day of these trials, rats were 
exposed to a 15 sec delay for five trials, followed by a 30 sec delay for five trials. On the 
second day of these trials, rats were exposed to a 60 sec delay for five trials, followed by a 90 
sec delay for five trials. This procedure was the same for phase one and phase two of testing. 
A door was placed in C2 near each goal-box before the rat was introduced to the starting 
runway. Once the rat entered an arm, a second door was inserted behind it in the closest C1 
(see Figure 4) so that the rat could be detained for the appropriate delay. At the end of the 
waiting period, the door preventing access to the goal-box was removed and the rat was 
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allowed to eat the pellets. If the animal selected the arm associated with the small reward, C2 
was removed immediately after C1 was inserted so that no delay occurred between 
manipulations of the doors. 
 
3.4 Rationale for Behavioural Measures 
Anxiety was measured using the acoustic startle reflex (ASR) paradigm. The startle 
reflex is characterised by exaggerated or increased behavioural activity in response to an 
intense sensory stimulus (Li et al., 2009). Therefore, the ASR paradigm seemed particularly 
suitable for measuring anxiety in the current study. Furthermore, the paradigm has been 
widely used as a reliable nonverbal index of fear and anxiety in humans and animals (Bradley 
et al., 2001; Rosen and Schulkin, 1998). A great benefit of the ASR paradigm is that the 
response is purely reflexive and easily elicited (Li et al., 2009). Additionally, the test is 
widely used in behavioural research, giving it considerable face validity as a measure of 
anxiety in animals (van Nobelen and Kokkinidis, 2006). Also, the potentiated startle response 
(a test very similar to the simpler startle response paradigm) has shown substantial construct 
and predictive validity as a model for measuring anxiolytic processes i.e. those that prevent or 
reduce anxiety (Hijzen et al., 1995). The ASR paradigm is less invasive than tests that 
involve measuring the adrenal hormones or the weight of the adrenal glands, and are more 
reliable than tests relying on muscle tone or tail-pinch responses. 
Aggression was measured using the resident-intruder (R-I) paradigm, which is simple 
to use and doesn’t require the use of aversive stimulation or conditioning to elicit aggressive 
behaviours (Miczek, 1979). A range of alternative defense test batteries use a recently killed 
or anaesthetised rat to elicit the aggressive behaviours in the subject (Blanchard et al., 1998), 
while others involve cats or humans as the intruder (Blanchard et al., 2003). Previous 
experience in this laboratory has shown that the type of rat used in the current study is well-
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habituated to humans and does not seem to react aggressively toward cats. Furthermore, the 
R-I paradigm does not require the use of recently killed or anaesthetised rats. Therefore, the 
R-I intruder paradigm is a much more suitable and humane method for assessing aggression 
than these other methods. An earlier study using a similar test to the R-I paradigm, the rat 
exposure test (which involves an intruder rat being placed behind a mesh barrier), showed 
that all strains of rat tested exhibited defensive behaviours thereby indicating the value of this 
test in assessing aggressive and defensive behaviours (Yang et al., 2004). The removal of this 
mesh barrier in the R-I paradigm used in the current study allows for additional and more 
aggressive contact behaviours to be recorded, making it a more appropriate method for 
assessing aggression. Significant decreases in attack frequency after administration of 
tetrahydrocannabinol (THC), the psychoactive compound in marijuana, in a dose dependent 
manner in resident mice, rats, and squirrel monkeys has been found which shows that the 
resident-intruder paradigm has a degree of species generality (Miczek, 1978). Additionally, 
the test’s predictive validity enables us to predict outcomes when applied to humans (Olivier 
and Young, 2002). 
 There are fewer choices of tests for impulsivity but most are generally a variation of 
the T-maze procedure used in the current study. They typically vary with how the cost 
involved to attain the greater of two rewards (or the tolerance to delay of reward) is produced. 
The 5-Choice Serial Reaction Time Task requires rats to detect brief flashes of light 
presented in a pseudorandom order in one of five spatial locations (Bari et al., 2008). 
Impulsivity is apparent when the rat responds before the onset of the stimulus. The training 
for this task takes 30-40 daily sessions. Due to time restrictions, and availability of the 
apparatus for this test, it was deemed not suitable for the current study. The T-maze apparatus 
however was readily available, and training takes only three daily sessions. A study using a 
T-maze to test for impulsivity found that all animals chose the high reward arm on the 
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majority of trials when the delay was equal to both the high and low reward arms (Denk et 
al., 2005). This shows that the rat does value the larger reward, and is likely to behave as 
expected when delays to the larger reward are introduced. The spontaneously hypertensive rat 
(SHR) is believed to be a valid model of ADHD and therefore impulsivity. Illustrating this 
are results from choice procedures showing that SHR’s are more impulsive than the Wistar-
Kyoto rats as defined by preference for the smaller, immediate reinforcer over larger, delayed 
ones (Fox et al., 2008). Sensitivity to delay of reinforcement was also found for the SHR and 
the genetically hypertensive rat, while not as much in their respective genetic control strains 
Wistar-Kyoto and Wistar (Sutherland et al., 2009). These studies effectively measured 
sensitivity to delay of reinforcement and their findings suggest that the T-Maze procedure 
used in the current study is a valid measure of impulsivity in the rat. 
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4.0 Statistical Analyses 
All raw data were analysed by a repeated measures analysis of variance (ANOVA) 
using the statistical programme SPSS v19. Analyses were repeated using the statistical 
programme Statisctica v9 to ensure that values were computed correctly. Separate 4 
(treatment) x 2 (testing phase/age) x 2(sex) factorial repeated measures ANOVAs were used 
on each measure. These were followed by one-way ANOVAs of each sex at each testing 
phase and post hoc Fisher PLSD tests. Statistical significance was assumed at values of 
p≤0.05. All values reported were rounded to two decimal places. Differences in behaviour 
across each testing phase were examined to see if the supplement had a greater effect on 
anxiety, aggression, and impulsivity over time. Sex differences in effects of EMP+ on 
behaviour were tested because so far, it is unknown whether the supplement affects males 
and females differently. 
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5.0 Results 
Each animal was tested once at both testing phases for anxiety, aggression, and 
impulsivity. For the startle and resident-intruder paradigm, subjects were 29 males and 34 
females, due to the exclusion of cohort four’s data from these analyses (see Table 7). No data 
was excluded from the T-maze analyses as this data was not affected by the earthquake. Even 
though the first cohort completed the T-maze test earlier than the other three cohorts, this 
difference in testing age and any effect on their responses was not significant or considered 
an issue. Due to time restraints, only males were tested for impulsivity in the T-maze. 
Therefore, in this case, the subjects were 40 male rats. 
Body weights were analysed to see if the diet concentration had a significant effect on 
the weights of the rats in each diet group. This is important because if the supplement caused 
a particular diet group to put on weight, testing results, particularly startle results, may have 
been affected. Mean ± S.E.M body weights (g) of the rats in the control, 1.25%, 2.5%, and 
5% supplement groups respectively were 186.91 ± 11.21, 191.07 ± 11.86, 182.32 ± 9.84 and 
192.14 ± 10.50. The treatment effect was not significant [F(3,59) = 0.17, p=0.92]. Not 
surprisingly, the male rats were significantly heavier (mean ± S.E.M = 232.03 ± 2.30) than 
the females [150.12 ± 1.26, F(1,61) = 1057.86, p<0.001]. 
There was either a significant main sex effect, or a sex × treatment interaction effect 
for startle amplitude and most resident-intruder behaviours. Therefore, separate graphs for 
each sex were displayed for each measure. As each sex had obviously reacted significantly 
differently in these cases, it was not appropriate to combine and average their responses. 
Furthermore, results from each testing phase were also represented separately in all graphs 
for the startle, resident-intruder, and T-Maze results to display what occurred at each phase 
because again, there was often a significant main effect of testing phase. Treatment group 
means were not averaged for the graphs. Because supplement treatment was the main 
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variable of interest, any nonsignificant trends could still be of interest with regard to 
suggesting possible future lines of research. 
Initially, repeated measures ANOVAs were carried out for all variables. Due to the 
significant interactions between sex and treatment for several of the measures, one-way 
ANOVAs were performed for each sex at each testing phase to see if there were suggestions 
of any specific effects of treatment on each sex at each testing age. While it is not standard 
practice to do so, particularly if there is not a significant treatment effect or interaction, this 
approach was adopted due to the exploratory nature of this research. It was also guided by the 
view that the primary objective of a study should determine which statistical tests are made to 
arrive at scientifically meaningful inferences (Winer, 1962). As there is abundant evidence 
that the two sexes can respond differently to pharmacologically active agents (Hughes, 2007) 
and that the effects of such agents can change over time (e.g., Beluzzi et al., 2004; Anderson 
and Hughes, 2008), the approach adopted seemed justified as it was felt that any suggestive 
findings in this hitherto unexplored area might help guide future research. Therefore, no firm 
conclusions should be drawn from the post hoc analyses following the one-way ANOVAs. 
They should be considered purely suggestive rather than conclusive. Also, one does not 
generally include statistical results of non-significant main and interaction effects. They have 
been included in the current study due to the nature of this research. Some of the non-
significant effects were clearly far from being significant, which is still informative. 
However, the few that were close to significance may have been significant if testing had not 
been interrupted by a 7.1 magnitude earthquake. Also, because this was the first study of its 
kind, reporting these near significant and not so significant results might be helpful for 
directing future studies. 
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5.1 Startle Results 
Data from cohort four was excluded from all startle analyses due to the effects of the 
September earthquake on their startle amplitudes. The startle amplitudes of cohort four were 
significantly higher than those of the other three cohorts, while the other three cohorts’ were 
not significantly different from each other. Furthermore, as can be seen in Table 5, cohort 
four is not an exact average representation of all treatment groups or each sex. Therefore, the 
effects of the earthquake on the startle amplitudes of cohort four are not represented equally 
in each diet group or sex, giving more reason to remove cohort four from data analyses. 
Unfortunately, due to the removal of cohort four’s data from the startle analyses, an unequal 
number of rats in each treatment group resulted (Table 8). Group numbers were reduced to as 
low as seven, particularly for males, for some of the concentration groups. 
 
Table 8. 
Reduced numbers of rats in each treatment group as a result of removing cohort four due to the September 
earthquake. 
Sex Diet N 
F 0% 10 
(N=34) 1.25% 7 
 
2.5% 10 
 
5% 7 
M 0% 7 
(N=29) 1.25% 8 
 
2.5% 7 
 
5% 7 
 
No significant startle amplitude differences were found between any of the four startle 
chambers, indicating that each chamber was calibrated correctly [F(3,59) = 0.17, p=0.91]. Of 
the 30 startle amplitudes collected for each rat, the first ten trials were discarded to reduce 
overall variance and the remaining 20 trials were reported (van Nobelen, 2006). Therefore, 
the variable of interest that was used for data analyses was an average of the last 20 startle 
amplitudes for each rat. 
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A repeated measures ANOVA found no significant main effect of supplement 
treatment on startle amplitude (p=0.680). There was a significant main effect of testing phase 
[F(1,55) = 11.38, p<0.001]. On average, startle amplitudes were higher at testing phase two 
(mean ± S.E.M=306.09 ± 21.74) than at testing phase one (241.83 ± 14.64). Ages of the rats 
at each testing phase and their corresponding developmental stage for each test can be found 
in Table 4. There was also a significant main effect of sex [F(1,55) = 10.83, p<0.01]. On 
average, males (361.72 ± 22.20) produced larger startle amplitudes than females (258.63 ± 
19.48). There was a significant interaction between sex and treatment [F(3,55) = 3.40, 
p<0.05]. With increasing diet concentration, male startle amplitudes decreased while female 
startle amplitudes increased. No other interaction effects were significant. There was not a 
significant interaction between testing phase and treatment [F(3,55) = 1.29, p=0.29], testing 
phase and sex [F(1,55) = 0.03, p=0.86], or between testing phase, treatment, and sex [F(3,55) 
= 0.76, p=0.52]. 
 Due to the main effect of sex and the significant interaction effect between sex and 
treatment, further one-way ANOVAs were carried out to see if supplement treatment was 
significant for each sex at each phase. There was not a significant treatment effect for males 
at phase one [F(3,25) = 2.13, p=0.12] or phase two [F(3,25) = 1.06, p=0.38], or for females at 
phase one [F(3,30) = 0.73, p=0.54] or phase two [F(3,30) = 2.04, p=0.13]. Fisher PLSD post 
hoc comparisons revealed three differences between supplement treatment groups, which are 
illustrated in Figure 5. Specifically, the male control group produced significantly larger 
startle amplitudes than the male 1.25% group (p<0.05) and the male 5% supplement group 
(p<0.05) at phase one, meaning they were more anxious. Therefore, the supplement reduced 
anxiety for males on the supplement. The female 5% diet group produced significantly larger 
startle amplitudes than the controls (p<0.05) at phase two, showing they were more anxious. 
Unlike the males, a larger dose of EMP+ increased anxiety. 
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Figure 5. Mean (±S.E.M) startle amplitude responses for males and females showing the differences in 
responses between each diet group at phase one and phase two of testing. * = significantly different from 
the control group (p<0.05). 
 
 Even though there were no main effects of supplement treatment on startle amplitude, 
it is clear that each sex reacted differently to the supplement. Males appeared to benefit from 
the supplement when tested at phase one (PND 52-53), which is illustrated by their lower 
startle amplitudes, while females were more anxious on the highest supplement strength 
when tested at phase two (PND 116-117), therefore producing higher startle amplitudes. 
 
5.2 Resident Intruder Results 
 Cohort four’s resident-intruder data was also excluded from all analyses because 
testing of cohort four happened very soon after the September earthquake (see Table 8). Also, 
they were housed for a prolonged period of time due to the earthquake i.e. 13 days compared 
to six or seven days for the other three cohorts. The difference in testing conditions that 
cohort four experienced compared to the other three cohorts justified their removal. A 
repeated measures ANOVA was carried out for the remaining subjects, and the results are 
presented in Table 9. For the main effect of treatment, values shown were averaged across 
sex and testing phase. For the main effect of sex, the values shown were averaged across 
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treatment groups and testing phase. For the main effect of testing phase, values shown were 
averaged across treatment groups and sex. Several behaviours that occurred so rarely in any 
treatment group were not analysed. These included mutual upright position, upright boxing, 
nose off, wrestle, push/nudge, pinning, kick, pursuit, escape, mount, and intruder shriek 
which left five behaviours for analysis (Table 9). 
 
Table 9. 
Means (±S.E.M) for resident intruder behaviour measures for each diet concentration for male and female 
rats at phase one and two of testing, and results of F tests from repeated measures ANOVA. 
Treatment Group Control 1.25% 2.50% 5% F p 
 
(n=17) (n=15) (n=17) (n=14) (3,55) 
 Latency to bite (sec)
a 
715.88(45.14) 642.77(54.21) 713.47(51.89) 710.25(50.16) 0.59 =0.626 
Anogenital Contact 14.41(1.21) 10.67(1.21) 11.21(1.03) 10.68(1.08) 2.32 =0.085 
Rough Paw
b
 10.35(1.47) 10.83(1.66) 10.35(1.35) 8.54(1.45) 0.77 =0.515 
Allogrooming
ab
 2.12(0.75) 2.63(0.82) 2.12(0.65) 2.11(0.63) 0.30 =0.829 
Bite
c 
1.76(0.56) 2.40(0.69) 2.06(0.68) 2.14(0.66) 0.20 =0.894 
Sex 
 
Male Female 
 
F p 
  
(n=29) (n=34) 
 
(1,55) 
 Latency to bite (sec) 
 
650.12(40.49) 736.19(30.46) 
 
3.36 =0.072 
Anogenital Contact 
 
8.79(0.62) 14.41(0.82) 
 
28.11 <0.001 
Rough Paw 
 
9.38(0.97) 10.65(1.09) 
 
1.04 =0.312 
Allogrooming 
 
1.50(0.37) 2.87(0.57) 
 
5.00 <0.05 
Bite 
 
3.09(0.60) 1.22(0.27) 
 
10.65 <0.01 
Testing Phase 
 
Phase One Phase Two 
 
F p 
  
(n=63) (n=63) 
 
(1,55) 
 Latency to bite (sec) 
 
551.51(37.89) 841.63(20.37) 
 
58.28 <0.001 
Anogenital Contact 
 
12.62(0.81) 11.03(0.83) 
 
2.75 =0.103 
Rough Paw 
 
15.19(1.01) 4.94(0.56) 
 
123.54 <0.001 
Allogrooming 
 
3.83(0.62) 0.65(0.22) 
 
41.87 <0.001 
Bite 
 
3.75(0.54) 0.41(0.18) 
 
40.35 <0.001 
a 
Phase × treatment × sex interaction significant (see text) 
b
 Treatment group × sex interaction significant (see text) 
c 
Phase × sex interaction significant (see text) 
 
In summary, there were no significant main effects of supplement treatment for any of 
the behaviours recorded (see Table 9). There were significant main effects of sex for 
anogenital contact, allogrooming, and bite. There were also significant main effects of phase 
for all variables except for anogenital contact. Significant interaction effects between 
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treatment and sex were found for rough paw and allogrooming, and were found between 
phase and sex for bite, but none were found between phase and treatment. An overall 
significant phase × treatment × sex interaction effect was found for latency to bite and 
allogrooming. These findings are explained in more detail in the following sections. As was 
done for the startle results, due to the main effects of sex and the significant interaction 
effects between sex and treatment, further one-way ANOVAs were carried out to see if 
supplement treatment was significant within each sex at each phase. As mentioned earlier, the 
results from the one-way ANOVAs and their post hoc results should be interpreted with 
caution, and are only indicative of possible treatment effects. 
 
5.2.1 Latency to Bite (sec) 
There was not a significant treatment effect for latency to bite, nor was there a 
significant main effect of sex (see Table 9 for further references to main effect statistics). 
There was however a significant main effect of testing phase. The time taken to perform a 
bite attack increased significantly from phase one (PND 52-53) to phase two (PND 116-117), 
suggesting decreased aggression. Additionally, there was a significant phase × treatment × 
sex interaction effect [F(3,55) = 2.84, p<0.05]. No significant interactions were found 
between treatment and sex [F(3,55) = 2.42, p=0.076], testing phase and treatment [F(3,55) = 
1.13, p=0.34], or between testing phase and sex [F(1,55) = 2.30, p=0.14]. 
A one-way ANOVA for males at phase one showed a suggestive treatment main 
effect [F(3,25) = 2.78, p=0.062], but no significant main effects of treatment were found for 
males at phase two [F(3,25) = 0.10, p=0.96], females at phase one [F(3,30) = 1.39, p=0.27], 
or for females at phase two [F(3,30) = 0.53, p=0.67]. Fisher PLSD post hoc comparisons 
showed that bite attack latencies for the male control group were significantly longer than 
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those of the male 2.5% supplement group at phase one (p<0.01) meaning that controls were 
less aggressive because they took longer to initiate a bite attack. 
 
 
Figure 6. Mean (±S.E.M) bite attack latency for males and females at phase one and phase two for all 
treatment groups. * = significantly different from control group (p<0.01). 
 
 It is clear from Figure 6 that bite attack latencies were significantly longer at phase 
two than phase one, and that supplement treatment did not significantly affect these, 
particularly at phase two. 
 
 5.2.2 Anogenital Contact 
 There was a significant main effect of sex for anogenital contact (see Table 9). 
Females performed anogenital contact significantly more often than males at both testing 
phases, which is clearly displayed in Figure 7. There were no significant main effects of 
treatment or testing phase. There were no significant interactions between treatment and sex 
[F(3,55) = 0.69, p=0.56], testing phase and treatment [F(3,55) = 0.39, p=0.76], testing phase 
and sex [F(1,55) = 0.08, p=0.78], or between testing phase, treatment, and sex [F(3,55) = 
0.66, p=0.58]. 
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One-way ANOVAs revealed a near significant main effect of treatment for males at 
phase one [F(3,25) = 2.51, p=0.08], but no significant main effects of treatment were found 
for males at phase two [F(3,25) = 0.42, p=0.74], females at phase one [F(3,30) = 0.56, 
p=0.65], or for females at phase two [F(3,30) = 1.12, p=0.36]. Fisher PLSD post hoc 
comparisons for the one-way ANOVA for males at testing phase one showed that the control 
group performed anogenital contact significantly more often than the 1.25% supplement 
group (p<0.05), which can be seen in Figure 7. 
 
 
 
Figure 7. Mean (±S.E.M) anogenital contact showing male and female responses for all treatment groups 
at both testing phases. * = significantly different from the control group (p<0.05). 
 
Although a main effect of supplement treatment was not found, it seems that being on 
any strength of the supplement reduces anogenital contact in males and females compared to 
controls. 
 
5.2.3 Rough Paw 
While there was not a significant main effect of treatment or sex, there was a 
significant main effect of testing phase (see Table 9). Rough paw occurred significantly more 
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frequently at phase one than phase two. There was also a significant interaction between sex 
and treatment [F(3,55) = 4.65, p<0.01]. Being on the supplement seemed to increase rough 
paw frequency for males, and decrease it for females, although this pattern was not perfectly 
linear. No significant interactions were found between testing phase and treatment [F(3,55) = 
1.28, p=0.29], or testing phase and sex [F(1,55) = 1.77, p=0.19]. There was a near significant 
interaction between testing phase, treatment, and sex [F(3,55) = 2.68, p=0.056]. 
A one-way ANOVA for females at phase one revealed a significant main effect of 
treatment [F(3,30) = 3.34, p<0.05]. This was likely due to the significant post hoc differences 
revealing that the 1.25% supplement group performed rough paw significantly more often 
than the 2.5% supplement group (p<0.05) and the 5% supplement group (p<0.05). There 
were no significant main effects of treatment for females at phase two [F(3,30) = 0.74, 
p=0.54], males at phase one [F(3,25) = 2.19, p=0.11], or males at phase two [F(3,25) = 1.76, 
p=0.18]. Post-hoc Fisher PLSD comparisons revealed some differences between treatment 
groups for the males. At phase one, the males in the 2.5% supplement group performed rough 
paw significantly more often than the males in the control group (p<0.05). Additionally, at 
phase two, the males in the 2.5% supplement group performed rough paw significantly more 
often than the males in the 1.25% supplement group (p<0.05). That is, for males, being on the 
supplement increased rough paw in the 2.5% group. These post hoc differences are illustrated 
on the graph in Figure 8. 
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Figure 8. Mean (±S.E.M) rough paw showing the differences between each diet concentration for testing 
phases one and two, males and females. * = significantly different from the 1.25% supplement group 
(p<0.05). ** = significantly different from the control group (p<0.05). 
 
5.2.4 Allogrooming 
 There was not a significant main effect of treatment for allogrooming but there was a 
significant main effect of sex (see Table 9). Females performed allogrooming significantly 
more often than males. There was also a significant effect of phase. Rats performed 
allogrooming more often at phase one than phase two. The interaction between sex and 
treatment was significant [F(3,55) = 4.65, p<0.01] due to the opposite patterns of responding 
of each sex at phase one. There was not a significant interaction between testing phase and 
treatment [F(3,55) = 0.41, p=0.74] or between testing phase and sex [F(1,55) = 2.48, p=0.12], 
but the interaction between testing phase, treatment, and sex was significant [F(3,55) = 7.46, 
p<0.001]. 
A one-way ANOVA for males at phase one revealed a significant main effect of 
treatment [F(3,25) = 5.23, p<0.01]. This was likely due to the high level of allogrooming by 
the 2.5% supplement group. Post hoc analyses showed that the allogrooming levels of the 
male 2.5% supplement group at phase one were significantly higher than the control group 
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(p<0.01), the 1.25% supplement group (p<0.01), and the 5% supplement group (p<0.05). A 
one-way ANOVA for females at phase one also showed a significant main effect of treatment 
[F(3,30) = 3.18, p<0.05]. This was likely due to the significantly higher levels of 
allogrooming by the 1.25% group than the 2.5% supplement group (p<0.01) for females at 
phase one. These findings are illustrated in Figure 9. There was not a significant main effect 
of treatment for males at phase two [F(3,25) = 0.81, p=0.50] or for females at phase two 
[F(3,30) = 0.03, p=0.99]. 
 
 
Figure 9. Mean (±S.E.M) allogrooming showing the differences between each diet concentration for 
testing phases one and two, males and females. * = significantly different from the 2.5% supplement 
group (p<0.01). ** = significantly different from the 2.5% supplement group (p<0.05). 
 
 Allogrooming levels at phase two were quite low, which probably contributed to the 
overall lack of a main treatment effect in males and females at phase two. 
 
5.2.5 Bite 
 There was not a significant main effect of supplement treatment for bite (see Table 9). 
There was a significant main effect of sex and a significant main effect of testing phase. 
Males performed a bite significantly more often than females, and bites occurred significantly 
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more often at phase one than phase two. These findings are illustrated in Figure 10. There 
was also a significant interaction between testing phase and sex [F(1,55) = 7.73, p<0.01]. 
Significant interactions were not found between treatment and sex [F(3,55) = 1.07, p=0.37], 
testing phase and treatment [F(3,55) = 0.23, p=0.87], or between testing phase, treatment, and 
sex [F(3,55) = 0.25, p=0.86]. 
One-way ANOVAs revealed no significant treatment main effects for males at phase 
one [F(3,25) = 0.31, p=0.82], males at phase two [F(3,25) = 0.60, p=0.62], females at phase 
one [F(3,30) = 0.52, p=0.67], or females at phase two [F(3,30) = 0.72, p=0.55]. 
 
 
Figure 10. Mean (±S.E.M) bite showing the differences between each diet concentration for testing phases 
1 and 2, males and females. 
 
 As for allogrooming, bite levels were particularly low at testing phase two, possibly 
contributing to the lack of treatment effects found. 
 
5.3 T-Maze Results 
 A repeated measures ANOVA was carried out for the T-maze data and the results are 
presented in Table 10. For the main effect of supplement treatment, values shown are 
averaged across testing phase. For the main effect of phase, values shown are averaged across 
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treatment groups. Values represent the percentage of times that a rat chose the small 
immediate reward over the larger delayed reward. Therefore, higher percentage values 
represent higher levels of impulsivity. Only males were tested for impulsivity, so there were 
no main or interaction effects involving sex for this measure 
 
Table 10. 
Means (±S.E.M) for all impulsivity test delays for each diet concentration at phase one and two of testing, 
and results of F tests from repeated measures ANOVA. 
Treatment Group Control 1.25% 2.50% 5% F p 
  (n=10) (n=10) (n=10) (n=10) (3,36)   
15sec Delay 36.00(6.09) 42.00(7.24) 30.00(4.92) 40.00(4.81) 0.90 =0.451 
30sec Delay 59.00(6.88) 54.00(6.17) 44.00(4.72) 67.00(6.03) 2.29 =0.095 
60sec Delay 72.00(4.21) 68.00(5.31) 70.00(4.70) 72.00(5.69) 0.14 =0.938 
90sec Delay 83.00(5.48) 81.00(4.70) 75.00(5.78) 82.00(4.57) 0.42  =0.741  
Testing Phase 
 
Phase One Phase Two 
 
F p 
    (n=40) (n=40)   (1,36)   
15sec Delay 
 
27.00(3.89) 47.00(3.76) 
 
13.95 <0.01 
30sec Delay 
 
47.00(4.45) 65.00(3.84) 
 
13.35 <0.01 
60sec Delay 
 
65.00(4.04) 76.00(2.60) 
 
5.56 <0.05 
90sec Delay   75.50(3.00) 85.00(4.04)    4.07 =0.051  
 
 There were no significant main effects of treatment for any length of delay (see Table 
10). Testing phase was significant for all lengths of delay, except for the 90sec delay, which 
was very close to being significant. Rats were significantly more impulsive at phase two 
(PND 127-130) than phase one (PND 92-96). There were no significant interactions between 
testing phase and treatment for the 15 second delay [F(3,36) = 0.56, p=0.65], the 30 second 
delay [F(3,36) = 1.13, p=0.35], the 60 second delay [F(3,36) = 0.54, p=0.66], or the 90 
second delay [F(3,36) = 0.31, p=0.82]. 
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Figure 11. Mean (±S.E.M) of the % of times the small immediate reward was chosen at (A) testing phase 
one and (B) testing phase two. All rats were males. Higher responses indicate impulsivity. * = significantly 
different from the 2.5% supplement group (p<0.05). 
 
 As expected, rats became more impulsive with increasing delays. However, this was 
not moderated by the strength of supplement that the rats were receiving. One-way ANOVAs 
at each phase revealed some differences in responses between supplement groups, which are 
displayed on the graph in Figure 11. Specifically, for the 30sec delay at phase two, post-hoc 
analyses showed that the 2.5% supplement group was significantly less impulsive than the 
control group (p<0.05) and the 5% supplement group (p<0.05). No other differences were 
found. Because close to no differences were found, the responses were averaged across all 
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delays to create a summary graph for testing phase one and two, allowing for easier 
comprehension of the effects of diet concentration on impulsivity (Figure 12). 
 
 
Figure 12. Mean (S.E.M) of the % of times the small immediate reward was chosen at testing phases one 
and two, averaged over delay to reinforcement. All rats were males. Higher responses indicate 
impulsivity. 
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6.0 Discussion of Results 
 In this study, rats were exposed to differing concentrations of a supplement diet of 
EMP+. Rats had constant access to a diet that contained 0%, 1.25%, 2.5% or 5% EMP+. Rats 
were first tested on measures of anxiety and aggression during adolescence (PND 52-53) and 
for impulsivity during early adulthood (PND92-96). They were tested again for anxiety and 
aggression during mid adulthood (PND 116-117) and for impulsivity during late adulthood 
(PND 127-130). Male and female rats were tested for anxiety and aggression to allow for 
possible sex differences in the effects of the supplement, and testing was carried out at two 
ages to see if the supplement had a cumulative effect over time as well as to assess the effects 
of EMP+ at different stages of development. 
 
6.1 Summary of Results 
 The results revealed a select number of significant behavioural differences across the 
measures as a result of supplement treatment. A summary of the main effects and interactions 
from the repeated measures ANOVAs are presented in Table 11. This table clearly shows the 
different effects found across the three behaviours investigated. It is clear that no main effects 
of treatment were found for any of the measures when repeated measures ANOVAs were 
carried out. For nearly all measures, there was a significant effect of phase, but this never 
interacted with treatment. Sex differences were quite often found, and this interacted with 
treatment half of the time. These findings will be explained in more detail in the following 
sections. 
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Table 11.  
Summary of main effects and interactions from repeated measures ANOVAs for anxiety, aggression, and 
impulsivity measures. 
  
T S P T × S P × T P × S P × S × T 
Anxiety Startle Amplitude -    - - - 
Aggression Latency to Bite (sec) - -  - - -  
 
Anogenital Contact -  - - - - - 
 
Rough Paw - -   - - - 
 
Allogrooming -    - -  
 
Bite -   - -  - 
Impulsivity 15sec Delay - n/a  n/a - n/a n/a 
 
30sec Delay - n/a  n/a - n/a n/a 
 
60sec Delay - n/a  n/a - n/a n/a 
 
90sec Delay - n/a - n/a - n/a n/a 
 
Trials Averaged - n/a  n/a - n/a n/a 
Note: A tick signifies that the result was significant, and a dash signifies that the result was not significant. 
T = treatment, S = sex, P = phase, n/a = not applicable (only males were tested for impulsivity, so results that 
included sex main or interaction effects were not gathered for this measure). 
 
 Exposure to the diet did not produce uniform effects on the anxious, aggressive, or 
impulsive behaviours of the rats. Instead, the supplement produced opposite behavioural 
effects in each sex for some of the aggression measures, showing that males and females 
reacted to the supplement in different ways. Supplement treatment increased aggression in 
one case as shown by a decrease in bite attack latencies in males on the supplement, but 
decreased aggression in another as shown by a decrease in frequency of rough paw in females 
on the supplement. Furthermore, while there were no significant main effects of treatment on 
startle amplitudes, the interaction between sex and treatment was significant, confirming that 
the supplement causes different behavioural outcomes in each sex. There were no main 
effects of treatment for impulsivity, nor were there any interaction effects. The results of the 
three tests are covered in more detail as follows. 
For the startle paradigm, there was not a significant supplement treatment effect on 
mean startle amplitudes when data was averaged across sex (see Figure 5 and the 
corresponding text). Supplement treatment also did not have a significant effect on mean 
startle amplitudes when each sex was assessed separately. However, the interaction between 
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treatment and sex was significant, showing that each sex reacted to the supplement in a 
different manner. Males tended to become less anxious, while females tended to become 
more anxious. For both sexes, startle amplitudes increased significantly from testing phase 
one to two. This was not expected as it was thought that rats would habituate to the testing 
apparatus over time (Koch, 1999). It is unclear why this happened, and possible reasons, such 
as prolonged anxiety as a result of the September earthquake and its aftershocks, are 
discussed later. 
 There were no main effects of supplement treatment for any of the aggression 
behaviours measured when data was averaged across sex. When each sex was assessed 
separately, supplement treatment did not have a statistically significant effect on bite attack 
latency, bite frequency or anogenital contact for any sex at either testing phase, although it 
did have a near significant effect on males’ bite attack latencies and anogenital contact at 
phase one (see previous text). Supplement treatment had a significant effect on males’ and 
females’ allogrooming at phase one, and in both cases this was not linear (see Figure 9). A 
significant treatment effect for rough paw was found for females at phase one (see Figure 8). 
No other significant treatment effects were found when each sex was assessed separately. 
 No significant main or interaction effects were found for supplement treatment for 
any of the delays tested in the T-maze. The supplement treatment did not influence the male 
rats’ impulsivity behaviour. Rats were significantly more impulsive at testing phase two 
(PND 127-130) than testing phase one (PND 92-96). Similar to the patterns found with the 
anxiety and aggression measures, the effects of the strength of EMP+ diet on impulsivity 
were not linear. For nearly every single delay, the rats on the 2.5% diet were least impulsive, 
as shown by them choosing the small immediate reward less often at both testing ages (see 
Figure 11). This is more clearly illustrated in Figure 12. Therefore, a diet strength of 2.5% 
seems most suitable for reducing impulsivity in the male rat during early adulthood (PND 92-
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96) and late adulthood (PND 127-130). It should be noted however that these differences 
were not significant, and are only suggestive of a trend. 
 
 6.1.1 Sex Differences 
There were significant sex differences found for startle and aggression measures, as 
well as some interaction effects with treatment. For startle amplitudes, there was a significant 
main effect of sex. On average, males produced larger startle amplitudes than females, which 
is not surprising since male body weights were significantly higher than those of females. 
Strangely, some studies have not found significant main effects of sex for startle amplitudes 
(Hughes et al., 2011; Lacy, Mactutus, and Harrod, 2011), even though the males in the first of 
these were significantly heavier than the females. It doesn’t seem likely that this is a result of 
diet consumption due to the fact that startle amplitudes for controls were significantly higher 
for the males (386.80 ± 68.89) than the females (176.23 ± 20.53) at the first testing age 
[F(1,55) = 17.01, p<0.001] and were also higher for the males (387.14 ± 75.57) than the 
females (189.27 ± 21.27) at the second testing age [F(1,55) = 6.16, p<0.05]. 
As outlined earlier, each sex reacted in a different manner to the supplement when 
tested for anxiety. Females showed a nearly perfect linear increase in startle amplitudes with 
increasing diet concentration, while males generally showed a decrease in startle amplitudes 
with increasing diet concentration at both testing ages (see Figure 5). This suggests that any 
strength of EMP+ is not appropriate for reducing anxiety in a female rat population in 
adolescence (PND 52-53) or mid adulthood (PND 116-117). Additionally, startle amplitudes 
for the females in the 5% diet group at the second testing age were unexpectedly high. It is 
possible that the large dose of EMP+ and the stress resulting from the earthquake 
compounded, therefore causing further anxiety, or that the high strength of EMP+ itself had a 
toxic effect. For males, startle amplitudes were the lowest at both testing ages when they 
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were on the 5% diet strength. Strangely, when on the 1.25% diet, their startle amplitudes 
were nearly equally as low as the 5% group, while amplitudes were much higher for the 
controls and the 2.5% diet group at both testing ages. There are a few explanations for this 
non-linear pattern. Firstly, each diet group may have been characteristically different before 
they started the diet, suggesting that the high startle amplitudes of the control and the 2.5% 
diet group were due to individual differences of those groups. Secondly, the earthquake may 
have had an impact on some rats more than others, resulting in varied responses across 
groups when tested for anxiety. A third explanation is simply that differing strengths of 
EMP+ have a selective non-linear effect on startle amplitudes in a normal rat population. 
Specifically, during adolescence (PND 52-53), a diet strength of 1.25% EMP+ results in 
significantly lower startle amplitudes than controls, with amplitudes increasing for those on 
the 2.5%, and resulting in the lowest startle amplitudes in those rats on the 5% diet. A similar 
pattern resulted in the males during mid adulthood (PND 116-117), with highest startle 
amplitudes in the 2.5% diet group instead of controls. 
Several sex differences were found for the aggression measures (see Table 9 for 
further references to sex differences in aggression measures). Females performed anogenital 
contact and allogrooming significantly more often than males. They also performed rough 
paw more often than males, but this difference was not significant. Males performed a bite 
attack significantly more often than females, and while their bite attack latency was shorter 
than the females’, it was not significantly shorter. It is thought that male rats are more 
aggressive than female rats, particularly when male rats are with other male rats, and that 
male rats engage in more play-fighting behaviour than female rats (Pellis et al., 1996). This is 
evidenced by the fact that males performed a bite attack significantly more often than the 
females, which is the most extreme form of aggression measured. However, from these 
findings it is impossible to conclude that one sex is more aggressive than the other due to the 
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range of main effects found. Particular aggression-related behaviours may be sex-specific. 
The literature testing aggression using the R-I paradigm is limited to male subjects, which 
makes it difficult to speculate further on this. 
For the males, most allogrooming occurred in those on the 2.5% diet. The male rats 
on the 1.25% and 5% diet were relatively similar to the controls. For the females, most 
allogrooming occurred amongst those on the 1.25% diet, significantly less amongst those on 
the 2.5% diet (which was completely opposite to the males), whereas the 5% diet group 
performed allogrooming to the same extent as the controls. While both patterns are not linear, 
the allogrooming behaviour of each sex basically mirrored each other. It is possible that a 
lower dose of EMP+, i.e. 1.25%, is more optimal for males because they allogroomed less 
when on this dose, and that a slightly higher dose, i.e. 2.5%, is optimal for females because 
they performed allogrooming the least when on this dose. However, this was only found at 
phase one of testing when rats were PND 52-53, so the result can be generalised no further 
than this age group. Allogrooming levels were too low at testing phase two (PND 116-117) 
for both sexes to come to any conclusions. The only other main effect found in a particular 
sex for an aggression measure was on females’ rough paw frequency at testing phase one (see 
Figure 8). The highest frequency of rough paw occurred in those females at PND 52-53 that 
were on the 1.25% diet, which was consistent with the allogrooming finding just mentioned. 
While not significant, bite also occurred most frequently and bite attack latencies were 
shorter in females at PND 52-53 when on the 1.25% diet, which also suggested increased 
aggression. Therefore, it seems that a diet consisting of 1.25%, which is the dose suggested to 
help with more general mental health problems, is not appropriate when aggression is the 
target problem for females (at least for rats).  
Significant interactions involving supplement treatment were also found for most of 
the aggression measures. As described earlier, significant interactions between sex and 
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treatment were found for allogrooming and rough paw, suggesting that the supplement 
worked differently for each sex. Additionally, there was a significant interaction effect 
between sex and phase for bite frequency, and a significant interaction between sex, 
treatment and phase for allogrooming and latency to bite. The interpretation of these 
interactions is difficult due to the low frequency of responding at the second testing age, the 
non-linear pattern of responding with increasing diet concentration, and any individual 
differences present in each treatment group. Furthermore, any interpretation of these is 
complicated by the impact that the earthquake likely had on responding. 
It is worth noting that some studies using EMP+ in human populations have not found 
sex differences, suggesting that both males and females benefit from the supplement. A 
database analysis using self-report data from 120 males and 238 females with a diagnosis of 
bipolar disorder showed a 41% reduction of symptoms from baseline after three months of 
consuming EMP+ (Gately and Kaplan, 2009). This decrease in symptoms was significant for 
both males and females. An unpublished study looking at the effects of the 7.1 magnitude 
September 2010 earthquake on anxiety in a normal healthy population found beneficial 
effects of EMP+ on anxiety in males and females (Julia Rucklidge, personal communication, 
October 17, 2011). Additionally, Schlebusch and colleagues (2000) found significant 
reductions in stress in a large population of males and females who consumed Berocca, 
showing that both sexes benefit from natural supplementation. These findings are in 
opposition to the finding of the current study that female rats’ anxiety increase with higher 
EMP+ concentrations, particularly after an earthquake. However, many factors need to be 
taken into consideration when interpreting the results of the current study, such as the 
efficiency of the diet administration, lack of baseline behavioural measurements, and low 
sample sizes. These issues are covered in more detail in the limitations section of this study. 
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 6.1.2 Testing Age Differences 
 Significant testing age differences were found for the majority of the tests. For 
anxiety, startle amplitudes were higher when the rats were older (PND 116-117) than when 
they were younger (PND 52-53). This is inconsistent with the idea that rats’ startle 
amplitudes decrease over time due to habituation as a result of repeated exposure to the 
startle apparatus (Koch, 1999). It is likely that the magnitude 7.1 September earthquake and 
the repeated exposure to frequent aftershocks had a prolonged effect on the rats’ anxiety 
levels, producing higher amplitudes at the second testing time. This observation was 
consistent with the idea that a more anxious rat will produce higher startle amplitudes (Koch, 
1999). There was not a significant interaction effect of testing age with treatment. Each sex’s 
pattern of responding remained the same from the first testing phase to the second, but was 
elevated during the second. This is consistent with the hypothesis that the effects of EMP+ 
would become more pronounced over time, although it was expected that anxiety would be 
reduced in both sexes for all treatment groups compared to controls, not increased. 
All aggression-related behaviours decreased significantly in frequency from testing 
phase one (PND 52-53) to testing phase two (PND 116-117) apart from anogenital contact 
which remained basically unchanged. This is not necessarily a result of continued exposure to 
the EMP+ diet, but may be due to decreased activity of rats as they get older (Scimonelli et 
al., 1999), and an increased tendency to engage in hyperactive play behaviours in early 
adolescence compared to older rats (Spear and Brake, 1983). There were no significant 
interaction effects of testing age with concentration for any of the five aggression behaviours. 
Therefore, similar to that of anxiety, the effect of diet strength on aggression was consistent 
over time. 
On average, rats were significantly more impulsive during late adulthood (PND127-
130) than early adulthood (PND 92-96). This is in contrast with the idea that impulsivity is at 
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its highest during early adolescence and declines steadily from the age of 10 onwards 
(Steinberg et al., 2008). It is unlikely that the earthquake caused an increase in impulsivity 
during the second testing phase due to the length of time since the earthquake that this was 
carried out. By the second testing phase, the rats had been on the supplement for 
approximately 100 days, so it is possible that taking EMP+ for an extended period of time 
increases the likelihood of impulsivity. It is also possible that after prolonged consumption of 
the EMP+ and pellet mix, the rats found the chocolate chips particularly satiating by the 
second phase of testing. The rats had also learned from testing at phase one that their food 
source would not return to free feeding until the end of testing, so they were more inclined to 
rush for the smaller reward, resulting in what looked like higher impulsivity when it may 
have been more of a “binge-eating” mentality due to the unreliability of their food source 
during testing. The effect that diet strength had on impulsivity over time was consistent, as 
evidenced by the lack of a significant interaction effect between testing age and treatment. 
 
6.2 Relationship to Previous Findings 
 There is no published literature on the effects of EMP+ on any types of behaviour in a 
rat population so there are no directly relevant studies to compare the results of the current 
study to. Even if there were, the occurrence of the 7.1 magnitude earthquake would make any 
comparisons difficult because there is no literature on how rats behave after earthquakes 
when on EMP+. However, it is known how a human population with ADHD behaves when 
on EMP+ after a large earthquake. The Christchurch 2011 7.1 magnitude earthquake 
provided a unique opportunity for an investigation into its effects in a population of adults 
with ADHD taking EMP+ in Christchurch at the time. Baseline measures of anxiety had 
already been collected before the earthquake and it was found that two weeks (but not one 
week) post-quake, the group taking EMP+ reported significantly less anxiety than controls 
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(Rucklidge et al., 2011). Therefore, it would be expected that rats on the supplement would 
have responses lower than those of controls. Surprisingly, this was not the case for the female 
rats whose control group produced the lowest startle amplitudes while the 5% diet groups 
startle amplitudes were particularly high. 
The studies assessing the effects of EMP+ in human populations that have a disorder 
have proven promising. Specifically, EMP+ successfully reduced symptoms associated with 
these disorders, including anxiety, aggression, and impulsivity. Similarly, there were some 
instances in the current study where EMP+ produced desirable effects on the rats’ anxiety, 
aggression, and impulsivity responses. Males benefited significantly more than females when 
it came to anxiety, which was illustrated by their decreased startle amplitudes when on the 
supplement compared to the increased startle amplitudes of the females.  While the 
populations of studies assessing the effects of EMP+ in humans with disorders were often 
made up of males and females, no reference to sex differences in outcomes have been made, 
and it is not possible to identify the sex of the participants and their particular outcomes from 
the articles. Therefore, even though desirable effects were found in the studies on humans, no 
conclusions can be made about the efficacy of the supplement for each sex. This makes it 
difficult to discuss and support the finding of the current study that females’ anxiety levels 
did not benefit from the supplement. 
When each sex was looked at separately, significant treatment effects for some of the 
aggression behaviours were found. Females performed rough paw less often than controls 
when on higher doses of the supplement during the first testing phase (PND 52-53), 
suggesting decreased aggression. Conversely, males were quicker to perform a bite attack 
when on any strength of diet at the first testing phase (PND 52-53) compared to controls, 
with those in the 2.5% supplement group performing a bite attack significantly faster than the 
control group, which suggests increased aggression as a result of taking the supplement. 
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Again, the consistency of this finding with previous research cannot be commented on 
because studies that found beneficial effects of EMP+ on aggression measures in human 
populations did not make reference to sex differences. 
There are no studies on the effects of EMP+, let alone any of its ingredients, on 
impulsivity in a rat population. Studies of human populations have consistently shown 
improvements in impulsivity after taking EMP+. However, the current study found no main 
effect of treatment for impulsivity. 
 It is possible to compare the results of the current study to previous research looking 
at the effects of single nutritional elements of EMP+ on anxiety, aggression, or impulsivity. 
The current study found no significant main effect of treatment on anxiety. Similarly, 
Dopheide and Morgan (2008) found no change in anxiety levels after administration of 
vitamin A. However, other studies do not support this finding. Hughes and colleagues (2011) 
found a decrease in anxiety after vitamin C and E consumption, while another study found 
increased anxiety in rats after vitamin E consumption (Kolosova et al., 2006), suggesting that 
the effects on anxiety are dependent on the vitamin studied. This has important implications 
for the use of EMP+ because it shows that not all of its ingredients are necessarily beneficial 
for reducing anxiety. 
 The literature looking at the effects of specific vitamins and minerals on aggressive 
behaviour indicates decreased aggression in most cases. However, the current study found 
mixed effects on aggression, with some aggressive behaviour increasing and some decreasing 
in frequency. It is important to remember that the current study evaluated a multi-ingredient 
formula, and that results from single nutrient studies are not necessarily indicative of what 
their effects will be when combined. 
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7.0 General Discussion 
 Up until this point, any discussion has been specifically based on the results of the 
current study and their relationship to previous results. This section aims to evaluate the 
current study with regards to its quality, and to discuss the implications of this study. 
 
7.1 Methodological Strengths 
 Firstly, as clearly stated in section 3.4 Rationale for Behavioural Measures, the 
validity and reliability of the three measures used were of a high standard. Several methods 
for testing anxiety, aggression, and impulsivity were considered, and the most suitable were 
chosen for this study. Consequently, there can be confidence in the methods used. 
 Another major strength of this study was the use of rats as subjects. The use of rats 
allowed for control over the experimental conditions of the study, reducing the confounding 
variables associated with testing humans. Therefore, substance abuse, missed appointments, 
and not taking the supplement were not an issue for this study. All of the rats’ experiences 
were the same because they were handled, weighed, treated, and tested in the same manner. 
Consequently, significant results could be attributed to the effects of the supplement with a 
higher degree of confidence. An additional advantage of using rats is their faster rate of 
development compared to humans. Therefore, time differences could be assessed more 
efficiently and the implications of the results found can be applied to humans before clinical 
trial results are available. While direct extrapolation of results to humans should be done with 
caution, animal models have been proven useful in predicting responses in humans. 
 The use of a control group and two testing phases allowed for a more in-depth 
investigation into whether the supplement was responsible for the effects on the rats’ 
behaviour in each experimental group. Having a control group meant that comparisons could 
be made between the groups on the supplement and a group that has never taken the 
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supplement. Differences in behaviour over time due to age would show up in the control 
group, which could be taken into account when drawing conclusions about changes in 
treatment groups. If the behaviour of the control group did not change over time, then it was 
more likely that any changes over time found in treatment groups were solely attributable to 
the treatment. This is the ideal scenario, but the impact of the earthquake further confounded 
any interpretation of treatment effects, particularly over time. 
 It is quite common for experiments to use only male rats as subjects. The use of 
female as well as male rats in this study allowed for investigation of the different effects of 
the supplement on each sex. This proved beneficial because a number of sex differences and 
interactions with treatment were found. This is important because the supplement is intended 
for use in both sexes in a human population. Females are fundamentally different from males 
and it is just as vital to know whether the supplement works for or produces any harmful 
effects in females. 
 Finally, but of no less importance, this study is the first of its kind. No studies have 
looked at the effects of EMP+ in a normal rat population. This study was able to provide 
important preliminary findings to guide future research. Furthermore, the identification of 
any limitations as a result of the current study will help improve the quality of future 
research. 
 
7.2 Methodological Limitations  
 The most disappointing and disrupting limitation of this study was the 7.1 magnitude 
earthquake that struck during the middle of testing (see Figure 3). This produced changes in 
the rats’ behaviour that confounded the results of the current study. As a result of the 
earthquake, data from cohort four was removed from analyses due to significantly higher 
startle responses that were measured soon after the earthquake resulting in smaller sample 
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sizes (see Table 7) and reduced strength and power of the results. It is also difficult to 
interpret the findings at the second testing time because by this stage, all rats had been 
exposed to several frequent large aftershocks. Therefore, it is hard to be sure whether 
significant effects found over time were due to testing age differences, the supplement, or the 
earthquake itself. The most obvious effect of the earthquake was the resulting significant and 
unexpected increase in startle amplitudes. It is likely that the aggression and impulsivity 
findings were affected similarly. It is difficult to evaluate the extent of the effects of the 
earthquake on these behaviours due to the uncontrolled nature of its occurrence and the 
abundance of aftershocks following the initial earthquake. 
Rats in each experimental group were not tested on each measure before going on the 
supplement. Therefore, there are no baseline results for each experimental group. It is 
possible that the cohorts were significantly different to each other on measures of anxiety, 
aggression, and impulsivity before going on the supplement due to individual differences in 
the characteristics of each cohort. This may explain strange results due to characteristics of 
the groups that were not established before the rats went on the supplement such as the non-
linear pattern of allogrooming frequency by males and females. Establishing baseline 
measures of anxiety, aggression, and impulsivity would have allowed for the control of 
individual differences in each cohort. Additionally, time constraints meant that female rats 
were not tested for impulsivity. Therefore, comparisons between sexes for impulsivity were 
not able to be made. 
It was difficult to measure how much each rat ate because they were housed in cages 
of two to four rats, and they threw their food around. Therefore, it was difficult to establish 
whether each rat was getting the appropriate amount of EMP+. Housing the rats in their own 
cage and providing the EMP+ in their water supply would have allowed for closer monitoring 
of their EMP+ consumption. 
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Finally, there was little control over the number of rats that were supplied in each 
cohort. Newborn rats were available bi-weekly, and numbers were dependent on how many 
were born and how much demand there was from other projects. Therefore, it was not 
possible to gain a representative number of each sex from all four diet concentrations in each 
cohort. To allow for this, it would have been necessary to receive 24 rats each time, with half 
being male and half being female, and three of each sex being allocated to each of the four 
diet concentrations. Doing so would have allowed for the inclusion of the data from cohort 
four that was excluded from the current study because the cohort would have been an average 
representation of the other cohorts i.e., each sex and each diet group would have been 
affected similarly and any effects of the earthquake could have been averaged across all 
treatment groups. 
 
7.3 Implications 
 This is the first study known to assess the effects of a multinutrient supplement on rat 
behaviour. The lack of available data makes the results of this study important. They add to 
the body of research that isn’t particularly straightforward, and currently only looks at single 
vitamins and minerals on rat behaviour. This research is a valuable stepping stone because it 
has helped identify gaps in the literature that need addressing, and has highlighted some 
important considerations that need attention when planning future research. The findings of 
the current study are important due to the quickening pace of the use of EMP+ in a human 
population. They have highlighted a need to establish a complete understanding of the effects 
of EMP+. 
 The most important implication was the finding that each sex exhibited significantly 
different anxiety and aggression behaviours when on the supplement. This has important 
clinical implications because the results suggest that the use of EMP+ is less suitable for 
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females due to heightened anxiety responses. It is unfortunate that several of the published 
studies on the effects of EMP+ in populations of humans that have disorders do not put much 
emphasis on sex differences, even though both males and females have been tested. It is 
therefore difficult to tell how much each sex benefited from the supplement compared to the 
other sex in these studies. However, as mentioned earlier, studies have found benefits of 
EMP+ in humans with bipolar disorder and on anxiety in a normal population in both males 
and females, suggesting that the supplement is beneficial for both sexes. 
 A few other negative effects of EMP+ on behaviour were found in the current study in 
addition to increased anxiety in females, as evidenced by increased aggression in some cases. 
Specifically, there was a near significant decreasing trend of bite attack latency with 
increasing diet strength for adolescent males (PND 52-53), suggesting they were quicker to 
perform a bite attack when on higher concentrations of EMP+. Additionally, males on a diet 
of 2.5% EMP+ performed allogrooming significantly more often than the control group 
during adolescence, again suggesting increased aggression as a result of taking the 
supplement. It is important to remember that the current study was affected by a severe 
earthquake during testing, and that increases in any of the behaviours measured may be a 
result of this. However, negative results were still found and it is necessary to see whether or 
not future research will replicate these. This could be important, particularly when EMP+ is 
given to a human population. 
 Overall, it is likely that a diet strength of 1.25% is most suitable for a population 
without a mental health disorder. Apart from the high frequency of the female rat’s rough 
paw and allogrooming at testing phase one when on the 1.25% diet, behaviour when on this 
dose strength was in the most part reduced compared to other diet strengths. In contrast, 
startle amplitudes were notably higher when on the 2.5% diet strength for males and the 5% 
diet strength for females. Additionally, males consistently performed rough paw, 
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allogrooming, and a bite attack more frequently when on the 2.5% diet than any other diet 
strength, and also performed these behaviours more frequently when on the 5% diet than the 
1.25% diet. They were also quicker to perform a bite attack when on the 2.5% diet at testing 
phase one. Therefore, a diet strength of 2.5% (15 capsules a day) and 5% (30 capsules per 
day) may not be suitable for a human population that does not have a disorder. Further 
research is necessary to confirm this.  
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8.0 Future Directions 
 This was the first study of its kind, so there is a definite need for future research. Most 
importantly, although not under our control, future research needs to take place in the absence 
of earthquakes. The best research is research that has minimal confounding variables 
affecting the outcomes of the study. The effect of earthquakes on those taking the supplement 
is a whole other avenue of research, and is not at the forefront of the current research at this 
stage. 
 The limitations of this study need to be addressed in future research. It is clearly 
important to test both sexes for all measures because it is apparent that EMP+ produces 
different effects on anxiety and aggression in male and female rats. Sex differences would 
probably have been found in impulsivity also, and testing both sexes would have shown the 
direction of these differences. Future research should ensure that baseline data are gathered, 
and that cohorts are representative of the whole population, to avoid the problems 
encountered by the current study. 
If similar studies are to be carried out again, it would be appropriate to mix the EMP+ 
into the rats’ drinking water to solve the problem of food being thrown around the cage. 
Additionally, each rat should be provided with their own drinking water. This can be 
achieved by having two rats in each cage separated by a mesh barrier to still allow for 
socialisation. Doing both of these would have allowed for direct measurement of the amount 
of EMP+ consumed by each rat in the current study. However, this method still involves self-
administered consumption so, while the water would contain either 1%, 1.25%, 2.5% or 5% 
of EMP+, each rat will not necessarily receive the same amount of EMP+ as another rat in 
the same diet group. Injection of the EMP+ would allow for further control over 
administration, meaning that each rat could receive the exact amount of EMP+ as each other 
rat in its diet group on a regular basis. It would be necessary to convert the EMP+ powder 
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into a substance that can be injected. Also, since the research on supplementation using 
EMP+ is based on there being an underlying nutritional deficiency, it would be worthwhile 
including pre- and post-supplementation blood tests to check if any deficiencies are 
ameliorated, in addition to symptom assessments. It is likely that all of these ideas would 
have been considered if time had allowed for it. Future research would need to be planned 
well ahead to ensure that all of these limitations are considered and addressed. Additionally, 
larger sample sizes allow for larger power and therefore confidence in results. Larger samples 
also act as a defense against having to eliminate data, and would have been beneficial in the 
current study due to lost data as a result of the earthquakes. 
There is scope for  assessing the effects of EMP+ on a range of other behaviours such 
as sleeping problems or low mood, whether the population has a disorder or not. Also, even 
though EMP+ has already been tested in people with disorders such as ADHD, OCD, and 
bipolar disorder, it would be suitable to test the supplement in a “disordered” rat population 
such as the SHR, which is an animal model of ADHD. As explained previously, rat studies 
provide controlled results in which we can have more confidence in than those of human 
studies. 
 Gathering inter-observer reliability data for the aggression measures should be 
considered because if reliability is found to be high, more confidence could be placed in the 
results found. This was not done in the current study, and the descriptions and recordings of 
the aggression measures may have been subject to bias. However, it was ensured that all 
behaviours were defined appropriately because they were based on previous valid and 
reliable definitions. It was not possible to gather inter-observer reliability data for the startle 
response or the impulsivity T-maze test because there were no subjective influences in these 
paradigms. 
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 A large body of research should be aimed at establishing the effects of each individual 
ingredient of EMP+ on the behaviours it is tested on because this research is incomplete, 
particularly in a rat population. Also, identification of the mechanisms of action of the 
ingredients of EMP+ and how they specifically affect behaviours such as anxiety, 
impulsivity, and aggression is paramount. While this will be particularly difficult, doing so 
will allow us to move on from speculated hypothesis to a more in depth and confident 
understanding of exactly how multinutrient supplements such as EMP+ are producing their 
effects on behaviour. 
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9.0 Conclusions 
 Earthquakes aside, there is still more than a glimmer of hope for EMP+. The current 
study has shown that males and females behave differently on the supplement, and that in 
some cases it has beneficial effects on anxiety, aggression, but not necessarily impulsivity in 
a normal healthy rat population. It is unfortunate that the earthquake has made it difficult to 
come to solid conclusions. With the earthquake in mind, and in light of the evidence from 
human studies, it would be foolish to dismiss the findings of the current study. 
This study is the first of its kind and has highlighted some important limitations that 
need addressing such as the administration of the supplement, and gathering baseline data to 
help rule out individual differences in responding. The main thing to get from this research is 
that the supplement is doing something, and it is necessary for structured research to continue 
in order to establish exactly what this is.  
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